0001318268 2026-01-01 2026-03-31 0001318268 2026-05-15 0001318268 2026-03-31 0001318268 2025-12-31 0001318268 us-gaap:SeriesAPreferredStockMember 2026-03-31 0001318268 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001318268 us-gaap:SeriesCPreferredStockMember 2026-03-31 0001318268 us-gaap:SeriesCPreferredStockMember 2025-12-31 0001318268 us-gaap:SeriesBPreferredStockMember 2026-03-31 0001318268 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001318268 us-gaap:SeriesDPreferredStockMember 2026-03-31 0001318268 us-gaap:SeriesDPreferredStockMember 2025-12-31 0001318268 us-gaap:SeriesEPreferredStockMember 2026-03-31 0001318268 us-gaap:SeriesEPreferredStockMember 2025-12-31 0001318268 mdex:SeriesEOnePreferredStockMember 2026-03-31 0001318268 mdex:SeriesEOnePreferredStockMember 2025-12-31 0001318268 us-gaap:SeriesFPreferredStockMember 2026-03-31 0001318268 us-gaap:SeriesFPreferredStockMember 2025-12-31 0001318268 us-gaap:SeriesGPreferredStockMember 2026-03-31 0001318268 us-gaap:SeriesGPreferredStockMember 2025-12-31 0001318268 us-gaap:SeriesHPreferredStockMember 2026-03-31 0001318268 us-gaap:SeriesHPreferredStockMember 2025-12-31 0001318268 2025-01-01 2025-03-31 0001318268 mdex:MezzanineEquityMember 2025-12-31 0001318268 us-gaap:CommonStockMember 2025-12-31 0001318268 us-gaap:PreferredStockMember 2025-12-31 0001318268 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001318268 us-gaap:RetainedEarningsMember 2025-12-31 0001318268 mdex:MezzanineEquityMember 2024-12-31 0001318268 us-gaap:CommonStockMember 2024-12-31 0001318268 us-gaap:PreferredStockMember 2024-12-31 0001318268 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001318268 us-gaap:RetainedEarningsMember 2024-12-31 0001318268 2024-12-31 0001318268 mdex:MezzanineEquityMember 2026-01-01 2026-03-31 0001318268 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001318268 us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001318268 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001318268 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001318268 mdex:MezzanineEquityMember 2025-01-01 2025-03-31 0001318268 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001318268 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001318268 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001318268 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001318268 mdex:MezzanineEquityMember 2026-03-31 0001318268 us-gaap:CommonStockMember 2026-03-31 0001318268 us-gaap:PreferredStockMember 2026-03-31 0001318268 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001318268 us-gaap:RetainedEarningsMember 2026-03-31 0001318268 mdex:MezzanineEquityMember 2025-03-31 0001318268 us-gaap:CommonStockMember 2025-03-31 0001318268 us-gaap:PreferredStockMember 2025-03-31 0001318268 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001318268 us-gaap:RetainedEarningsMember 2025-03-31 0001318268 2025-03-31 0001318268 2021-12-26 2021-12-28 0001318268 mdex:PromissoryNoteMember 2026-01-01 2026-03-31 0001318268 mdex:PromissoryNoteMember 2025-01-01 2025-03-31 0001318268 mdex:PromissoryNoteMember 2025-01-01 2025-12-31 0001318268 2022-01-01 2022-01-14 0001318268 2022-01-14 0001318268 2022-02-14 0001318268 mdex:PromissoryNoteOneMember 2026-01-01 2026-03-31 0001318268 mdex:PromissoryNoteOneMember 2025-01-01 2025-03-31 0001318268 2025-01-01 2025-12-31 0001318268 mdex:PromissoryNoteTwoMember 2022-01-01 2022-01-14 0001318268 mdex:PromissoryNoteTwoMember 2026-01-01 2026-03-31 0001318268 mdex:PromissoryNoteTwoMember 2025-01-01 2025-03-31 0001318268 mdex:PromissoryNoteTwoMember 2025-01-01 2025-12-31 0001318268 2022-04-27 0001318268 2022-04-01 2022-04-27 0001318268 mdex:PromissoryNoteThreeMember 2026-01-01 2026-03-31 0001318268 mdex:PromissoryNoteThreeMember 2025-01-01 2025-12-31 0001318268 2023-02-04 2023-02-28 0001318268 2023-02-03 0001318268 2023-01-31 2023-02-03 0001318268 2023-12-31 0001318268 us-gaap:PrivatePlacementMember 2021-11-02 0001318268 mdex:SeriesOneMember 2021-12-31 0001318268 mdex:SeriesOneMember 2022-12-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesOneOneMember 2021-08-01 2021-08-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesOneOneMember 2021-08-31 0001318268 mdex:OperatingInterestOneMember mdex:SeriesOneOneMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestOneMember mdex:SeriesOneOneMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesOneTwoMember 2022-04-01 2022-04-05 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesOneTwoMember 2022-04-05 0001318268 mdex:OperatingInterestOneMember mdex:SeriesOneTwoMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestOneMember mdex:SeriesOneTwoMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesTwoOneMember 2022-01-01 2022-01-05 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesTwoOneMember 2022-01-05 0001318268 mdex:OperatingInterestTwoMember mdex:SeriesTwoOneMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestTwoMember mdex:SeriesTwoOneMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesTwoFourMember 2023-01-10 0001318268 mdex:CommonStocksMember mdex:SeriesTwoFourMember 2023-01-10 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesTwoFourMember 2023-01-01 2023-01-10 0001318268 mdex:SeriesTwoFourMember 2023-01-10 0001318268 mdex:OperatingInterestTwoMember mdex:SeriesTwoFourMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestTwoMember mdex:SeriesTwoFourMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesTwoFiveMember 2023-01-10 0001318268 mdex:OperatingInterestTwoMember mdex:SeriesTwoFiveMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestTwoMember mdex:SeriesTwoFiveMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesThreeOneMember 2022-02-11 0001318268 mdex:CommonStocksMember mdex:SeriesThreeOneMember 2022-02-11 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesThreeOneMember 2022-02-01 2022-02-11 0001318268 mdex:SeriesThreeOneMember 2022-02-11 0001318268 mdex:OperatingInterestThreeMember mdex:SeriesThreeOneMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestThreeMember mdex:SeriesThreeOneMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesThreeTwoMember 2022-02-11 0001318268 mdex:CommonStocksMember mdex:SeriesThreeTwoMember 2022-02-11 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesThreeTwoMember 2022-02-01 2022-02-11 0001318268 mdex:SeriesThreeTwoMember 2022-02-11 0001318268 mdex:OperatingInterestThreeMember mdex:SeriesThreeTwoMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestThreeMember mdex:SeriesThreeTwoMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFourOneMember 2022-05-05 0001318268 mdex:CommonStocksMember mdex:SeriesFourOneMember 2022-05-05 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFourOneMember 2022-04-01 2022-05-05 0001318268 mdex:SeriesFourOneMember 2022-05-05 0001318268 mdex:OperatingInterestFourMember mdex:SeriesFourOneMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestFourMember mdex:SeriesFourOneMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFourTwoMember 2022-06-24 0001318268 mdex:CommonStocksMember mdex:SeriesFourTwoMember 2022-06-24 0001318268 mdex:CommonStocksMember mdex:SeriesFourMember 2022-06-24 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFourTwoMember 2022-06-01 2022-06-24 0001318268 mdex:SeriesFourTwoMember 2022-06-24 0001318268 mdex:OperatingInterestFourMember mdex:SeriesFourTwoMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestFourMember mdex:SeriesFourTwoMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFiveOneMember 2022-05-05 0001318268 mdex:CommonStocksMember mdex:SeriesFiveOneMember 2022-05-05 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFiveOneMember 2022-04-01 2022-05-05 0001318268 mdex:OperatingInterestFiveMember mdex:SeriesFiveOneMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestFiveMember mdex:SeriesFiveOneMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFiveTwoMember 2022-05-05 0001318268 mdex:CommonStocksMember mdex:SeriesFiveTwoMember 2022-05-05 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFiveTwoMember 2022-04-01 2022-05-05 0001318268 mdex:OperatingInterestFiveMember mdex:SeriesFiveTwoMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestFiveMember mdex:SeriesFiveTwoMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFiveThreeMember 2022-10-14 0001318268 mdex:CommonStocksMember mdex:SeriesFiveThreeMember 2022-10-14 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFiveThreeMember 2022-10-01 2022-10-14 0001318268 mdex:OperatingInterestFiveMember mdex:SeriesFiveThreeMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestFiveMember mdex:SeriesFiveThreeMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFiveFourMember 2022-12-15 0001318268 mdex:CommonStocksMember mdex:SeriesFiveFourMember 2022-12-15 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesFiveFourMember 2022-12-01 2022-12-15 0001318268 mdex:OperatingInterestFiveMember mdex:SeriesFiveFourMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestFiveMember mdex:SeriesFiveFourMember 2025-01-01 2025-03-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesSixOneMember 2022-09-16 0001318268 mdex:OperatingInterestSixMember mdex:SeriesSixOneMember 2026-01-01 2026-03-31 0001318268 mdex:OperatingInterestSixMember mdex:SeriesSixOneMember 2025-01-01 2025-03-31 0001318268 mdex:SeriesOneMember 2026-03-31 0001318268 mdex:SeriesOneMember 2025-12-31 0001318268 mdex:SeriesTwoMember 2026-03-31 0001318268 mdex:SeriesTwoMember 2025-12-31 0001318268 mdex:SeriesThreeMember 2026-03-31 0001318268 mdex:SeriesThreeMember 2025-12-31 0001318268 mdex:SeriesFourMember 2026-03-31 0001318268 mdex:SeriesFourMember 2025-12-31 0001318268 mdex:SeriesFiveMember 2026-03-31 0001318268 mdex:SeriesFiveMember 2025-12-31 0001318268 mdex:SeriesSixMember 2026-03-31 0001318268 mdex:SeriesSixMember 2025-12-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesOneOneMember 2021-08-31 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesOneTwoMember 2022-04-05 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesTwoFourMember 2023-01-10 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesTwoFiveMember 2023-01-01 2023-01-10 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesTwoFiveMember 2023-01-10 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesThreeOneMember 2022-02-11 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesThreeTwoMember 2022-02-11 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesFourOneMember 2022-05-05 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesFourTwoMember 2022-06-24 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesFiveOneMember 2022-05-05 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesFiveTwoMember 2022-05-05 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesFiveThreeMember 2022-10-14 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesFiveFourMember 2022-12-15 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:SeriesSixOneMember 2022-09-01 2022-09-16 0001318268 mdex:UnsecuredNotesPayableOneMember mdex:CommonStocksMember mdex:SeriesSixOneMember 2022-09-16 0001318268 mdex:SecuritiesPurchaseAgreementMember 2021-02-17 0001318268 2021-02-01 2021-02-17 0001318268 us-gaap:CommonStockMember 2021-02-17 0001318268 mdex:PreferredSeriesFSharesMember 2021-02-17 0001318268 2024-02-17 0001318268 mdex:ConvertibleNoteMember 2021-09-24 0001318268 2021-09-24 0001318268 mdex:PreferredSeriesFSharesMember 2026-03-31 0001318268 2023-01-01 2023-02-01 0001318268 2023-02-01 0001318268 2021-12-31 0001318268 2021-01-01 2021-12-31 0001318268 2022-01-01 2022-12-31 0001318268 2022-12-31 0001318268 2023-01-01 2023-12-31 0001318268 2024-01-01 2024-12-31 0001318268 us-gaap:SeriesAPreferredStockMember 2020-07-28 0001318268 us-gaap:SeriesAPreferredStockMember 2020-07-01 2020-07-28 0001318268 us-gaap:SeriesBPreferredStockMember 2020-07-28 0001318268 us-gaap:SeriesBPreferredStockMember 2020-07-01 2020-07-28 0001318268 srt:DirectorMember us-gaap:SeriesBPreferredStockMember 2021-02-17 0001318268 us-gaap:SeriesBPreferredStockMember mdex:LicenseAgreementMember 2020-07-31 0001318268 us-gaap:SeriesBPreferredStockMember mdex:LicenseAgreementMember 2020-07-01 2020-07-31 0001318268 us-gaap:SeriesAPreferredStockMember 2020-07-01 2020-07-31 0001318268 us-gaap:SeriesBPreferredStockMember 2020-07-01 2020-07-31 0001318268 2020-07-01 2020-07-31 0001318268 2020-01-01 2020-12-31 0001318268 us-gaap:SeriesBPreferredStockMember 2020-07-31 0001318268 mdex:CZJLicenseIncMember 2021-02-01 2021-02-16 0001318268 mdex:CZJLicenseIncMember 2021-02-16 0001318268 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-12-31 0001318268 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001318268 us-gaap:SeriesCPreferredStockMember 2021-02-11 0001318268 us-gaap:SeriesCPreferredStockMember 2021-02-01 2021-02-11 0001318268 us-gaap:SeriesDPreferredStockMember 2021-03-26 0001318268 us-gaap:SeriesCPreferredStockMember 2021-03-26 0001318268 us-gaap:SeriesDPreferredStockMember 2021-03-01 2021-03-26 0001318268 us-gaap:SeriesDPreferredStockMember 2021-12-31 0001318268 us-gaap:SeriesDPreferredStockMember 2021-01-01 2021-12-31 0001318268 us-gaap:SeriesEPreferredStockMember 2021-03-26 0001318268 us-gaap:SeriesEPreferredStockMember 2021-03-01 2021-03-26 0001318268 mdex:SeriesEOnePreferredStockMember 2021-09-16 0001318268 mdex:SeriesEOnePreferredStockMember 2021-09-01 2021-09-16 0001318268 mdex:SeriesEOnePreferredStockMember mdex:ExchangeAgreementMember 2021-10-01 2021-10-11 0001318268 us-gaap:CommonStockMember mdex:ExchangeAgreementMember 2021-10-01 2021-10-11 0001318268 mdex:SeriesEOnePreferredStockMember 2021-10-11 0001318268 us-gaap:SeriesFPreferredStockMember 2021-12-31 0001318268 us-gaap:SeniorNotesMember us-gaap:SeriesFPreferredStockMember 2021-01-01 2021-12-31 0001318268 us-gaap:SeriesFPreferredStockMember 2021-01-01 2021-12-31 0001318268 us-gaap:SeriesFPreferredStockMember 2021-10-01 2021-10-11 0001318268 us-gaap:CommonStockMember 2021-10-01 2021-10-11 0001318268 us-gaap:SeriesGPreferredStockMember 2021-03-26 0001318268 srt:MinimumMember us-gaap:SeriesGPreferredStockMember 2021-08-18 0001318268 srt:MaximumMember us-gaap:SeriesGPreferredStockMember 2021-08-18 0001318268 us-gaap:SeriesGPreferredStockMember 2021-03-01 2021-03-26 0001318268 us-gaap:SeriesGPreferredStockMember 2021-12-31 0001318268 us-gaap:SeriesGPreferredStockMember 2021-10-23 2021-11-02 0001318268 us-gaap:SeriesHPreferredStockMember 2021-11-05 0001318268 us-gaap:SeriesHPreferredStockMember 2021-11-01 2021-11-05 0001318268 us-gaap:CommonStockMember mdex:ExchangeAgreementMember 2021-11-01 2021-11-11 0001318268 us-gaap:SeriesHPreferredStockMember mdex:ExchangeAgreementMember 2021-11-01 2021-11-11 0001318268 us-gaap:SeriesHPreferredStockMember 2021-11-11 0001318268 us-gaap:CommonStockMember 2025-12-01 2025-12-30 0001318268 2021-08-14 0001318268 us-gaap:SeriesGPreferredStockMember us-gaap:PrivatePlacementMember 2021-12-31 0001318268 us-gaap:SeriesGPreferredStockMember us-gaap:PrivatePlacementMember 2021-11-02 0001318268 us-gaap:WarrantMember 2025-12-31 0001318268 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001318268 us-gaap:WarrantMember 2026-03-31 0001318268 mdex:AgileCapitalFundingLLCMember 2024-02-01 2024-02-17 0001318268 us-gaap:SubsequentEventMember 2026-05-01 2026-05-05 iso4217:USD shares iso4217:USD shares pure false --12-31 2026 Q1 0001318268

-660455

-709477

-35299205

-34638750

1152500

10-Q true 2026-03-31 false 000-51302 MADISON TECHNOLOGIES, INC NV 85-2151785 2500 Westchester Avenue Suite 401 Purchase NY 10577 (212) 257-4193 No No Non-accelerated Filer true true false false 1761428576

90921

130568

90921

130568

3979715

3898315

923014 725582

1064834

2525500

2545500

8228889

7866912

7340093 7340093

24062044

23441236

50000000

0.001

100

100000

0.001

100

10000

0.001

100

0.001

3.32

230000

155000

155

0.001

1000

0.001

0.87

1152500

1153

0.001

1000

0.001

1000

4600

0.001

39895

0.001

6000000000

1678095243

1678095

9648639

-35299205

-34638750

-23971123

-23310668

90921

130568

39646

60976

46707

56904

86353

117880

-86353

-117880

574102

591597

-574102

-591597

-660455

-709477

-660455

-709477

-0.0004

1678095243

1603095243

1678095243

1678095

1347495

1348

9648639

-34638750

-23310668

-660455

1603095243

1603095

1347495

1348

9667389

-35299205

-23971123

1603095243

1603095

1347495

1348

9667389

-31658127

-20386295

-709477

1603095243

1603095

1347495

1348

9667389

-32367604

-21095772

-660455

-709477

-39646

-39647

61400

217160

361977

-197432

-90693

197432

90693

197432

90693

Note 1 Nature of Operations Madison Technologies Inc. (the “Company”) was incorporated on June 15, 1998 in the State of Nevada, and our shares of Common Stock are quoted on the Experts Market tier of the over-the-counter market operated by OTC Markets, Inc.

1998-06-15

Note 2 Going Concern The accompanying unaudited condensed consolidated interim financial statements have been prepared assuming we will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. For the period ended March 31, 2026, we generated no revenues from operations, incurred a net loss of $660,455 (March 31, 2025 - $709,477) and had a working capital deficit of $23,971,123 (December 31, 2025 - $23,310,668) and an accumulated deficit of $35,299,205 (December 31, 2025 - $34,638,750). It is management’s opinion that these matters raise substantial doubt about our ability to continue as a going concern for a period of twelve months from the issuance date of these consolidated financial statements. Our ability to continue as a going concern is dependent upon management’s ability to raise additional capital as needed from the sales of stock or debt, ongoing support from the Company’s largest shareholder, potential amalgamation or similar strategies that management is working on and to further implement our business plan. However, the Company may not be able to secure such financing in a timely manner or on favourable terms, if at all. Furthermore, if the Company issues equity securities to raise additional funds, its existing stockholders may experience dilution, and the new equity securities may have rights, preferences and privileges senior to those of the Company’s existing stockholders. The accompanying unaudited condensed consolidated interim financial statements do not include any adjustments that might be required should we be unable to continue as a going concern.

23971123 23310668

Note 3 Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) for interim financial information and the Securities and Exchange Commission (“SEC”) instructions to Form 10-Q and Article 8 of SEC Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements and should be read in conjunction with the Company’s audited consolidated financial statements for the years ended December 31, 2025 and 2024 and their accompanying notes. The accompanying unaudited condensed consolidated interim financial statements are expressed in United States dollars (“USD”). In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of financial position and results of operations for the interim periods presented have been reflected herein. Operating results for the interim periods presented herein are not necessarily indicative of the results that may be expected for the year ending December 31, 2026. The Company’s fiscal year-end is December 31. The unaudited condensed consolidated interim financial statements include the accounts of the Company and its wholly owned subsidiary. Significant intercompany accounts and transactions have been eliminated. Significant accounting estimates and assumptions The preparation of the unaudited condensed consolidated interim financial statements requires the use of estimates and assumptions to be made in applying the accounting policies that affect the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities. The estimates and related assumptions are based on previous experiences and other factors considered reasonable under the circumstances, the results of which form the basis for making the assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods. Significant accounts that require estimates include promissory notes, convertible notes and senior secured notes due to the use of discount rates. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Fair value of equity classified conversion feature and warrants</td></tr> </table> In determining the fair values of the equity classified conversion feature and warrants pursuant to debt financing transactions, the Company applies a market-based valuation technique using the most recent private placement price as a proxy for fair value. This valuation approach is considered a Level 3 fair value measurement within the fair value hierarchy due to the use of unobservable inputs. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Provisions</td></tr> </table> Provisions are recognized when the Company has a present obligation, legal or constructive, as a result of a previous event, if it is probable that the Company will be required to settle the obligation and a reliable estimate can be made of the obligation. The amount recognized is the best estimate of the expenditure required to settle the present obligation at the end of the reporting period, taking into account the risks and uncertainties surrounding the obligations. Provisions are reviewed at the end of each reporting period and adjusted to reflect the current best estimate of the expected future cash flows. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Contingencies</td></tr> </table> Contingencies can be either possible assets or possible liabilities arising from past events, which, by their nature, will be resolved only when one or more uncertain future events occur or fail to occur. The assessment of the existence and potential impact of contingencies inherently involves the exercise of significant judgment and the use of estimates regarding the outcome of future events. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Going concern</td></tr> </table> The Company evaluates its ability to continue as a going concern in accordance with ASC 205-40, Presentation of Financial Statements – Going Concern. This assessment requires significant judgment and involves the evaluation of relevant conditions and events that are known or reasonably knowable at the date the financial statements are issued, including the Company’s current financial condition, obligations due within one year, expected future cash flows, access to capital, and management’s plans. The assessment involves inherent uncertainty, as it requires management to project future conditions and the effectiveness of any plans intended to address potential liquidity shortfalls. If substantial doubt about the Company’s ability to continue as a going concern is identified, management evaluates whether its plans will mitigate that doubt, and appropriate disclosures are made in the financial statements. Consolidation The accompanying unaudited condensed consolidated interim financial statements include the accounts of our wholly owned subsidiary, Blockchain.tv, Inc., which is dormant has not had operations since its inception. The functional and reporting currency of the Company and its subsidiaries are U.S. Dollar. Segment reporting Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and assessing performance. We identified our Chief Executive Officer as the chief operating decision maker. We operate in one operating segment. Our operating decision maker allocates resources and assesses performance at the consolidated level. Fair Value of Financial Instruments ASC 820 defines fair value, establishes a framework for measuring fair value and expands required disclosure about fair value measurements of assets and liabilities. ASC 820-10 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820-10 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: ● Level 1 – Valuation based on quoted market prices in active markets for identical assets or liabilities. ● Level 2 – Valuation based on quoted market prices for similar assets and liabilities in active markets. ● Level 3 – Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management’s best estimate of what market participants would use as fair value. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability. Fair value estimates presented herein are based on market assumptions and information available to management as of the reporting date. The carrying amounts of certain financial instruments approximate their fair values due to their short-term maturities or because their stated interest rates approximate market rates. These instruments include accounts payable and accrued expenses, interest payable on senior secured notes, promissory notes, convertible notes and senior secured notes. Convertible notes and other debt instruments In connection with the issuance of promissory and convertible notes, in certain instances we issued common share purchase warrants (the “Warrants”) that entitle the holder to purchase shares of our Common Stock at a specified fixed exercise price at any time within a time period specified within each Warrant. We evaluated the embedded conversion feature, if any, and the warrants and concluded that they qualified as equity instruments under Accounting Standards Codification (ASC) 815, Derivatives and Hedging, and ASC 815-40, Contracts in Entity’s Own Equity. The fair value of the Warrants were separated from the promissory and convertible notes and accounted for as a reduction of the carrying amount of the note with an increase to additional paid-in capital. With respect to the embedded conversion features in the senior secured notes, although they qualify as derivatives under ASC 815, the Company concluded that no reliable basis exists to determine their fair value as of the reporting date. Accordingly, no value has been assigned to the conversion features, and the derivative liability recognized pertains solely to the freestanding warrants. The fair value of the Warrants that represented a discount was amortized and included in the consolidated statements of operation over the term of each note using the effective interest method. Series A and C Convertible Preferred Stock The Series A and C convertible preferred stock (“Series A Preferred Stock” and “Series C Preferred Stock”) were accounted for as mezzanine equity. Loss per share Net Loss Per Share The Company has adopted the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 260-10 which provides for calculation of “basic” and “diluted” earnings per share. Basic loss per share of common stock is computed by dividing net loss $660,455 [2025 - $709,477] from continuing operation by the weighted average number of shares of common stock 1,678,095,243 [2025 - 1,603,095,243], outstanding during the period. Diluted loss per share of common stock is computed similarly to basic loss per share from continuing operations except the weighted average shares outstanding are increased to include additional shares from the assumed exercise of any common stock equivalents, if dilutive. Related Party Transactions We follow FASB ASC subtopic 850-10, “Related Party Transactions”, for the identification of related parties and disclosure of related party transactions. Pursuant to ASC 850-10-20, related parties include: a) our affiliates; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) our principal owners; e) our management; f) other parties with which we may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. Material related party transactions are required to be disclosed in the consolidated financial statements, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which statements of operation are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which statements of operations are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. Income taxes The Company accounts for income taxes in accordance with ASC 740. The Company provides for Federal, State and Provincial income taxes payable, as well as for those deferred because of the timing differences between reporting income and expenses for consolidated financial statement purposes versus tax purposes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recoverable or settled. The effect of a change in tax rates is recognized as income or expense in the period of the change. A valuation allowance is established, when necessary, to reduce deferred income tax assets to the amount that is more likely than not to be realized. Recently Issued Accounting Pronouncements Accounting guidance recently adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”) to improve the disclosures regarding a public entity’s reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The Company is required to adopt the guidance in the fourth quarter of fiscal 2025, though early adoption is permitted. The Company adopted quarterly requirements of this guidance beginning in the first quarter of 2025 and the adoption has no material impact on the unaudited condensed interim consolidated financial statements. New accounting guidance not yet adopted In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures (“ASU 2023-09”) to provide disaggregated income tax disclosures on rate reconciliation and income taxes paid. The Company is required to adopt the guidance in the fourth quarter of fiscal 2026, though early adoption is permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements. In January 2025, the FASB issued a clarification by ASU 2025-01 Income Statement - Expense Disaggregation Disclosures (Topic 220): A new guidance related to expense disaggregation disclosures. This guidance requires additional disclosure of certain amounts included in the expense captions presented in the Statement of Income as well as disclosures about selling expenses. The new guidance will be effective for us beginning in 2027 on an annual basis and in the first quarter of 2028 on a quarterly basis and may be applied on either a prospective or retrospective basis. Early adoption of the guidance is permitted. The Company is currently evaluating the effect this new guidance will have on our disclosures. The Company continues to evaluate the impact of the new accounting pronouncement, including enhanced disclosure requirements, on our business processes, controls and systems.

Basis of Presentation The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) for interim financial information and the Securities and Exchange Commission (“SEC”) instructions to Form 10-Q and Article 8 of SEC Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements and should be read in conjunction with the Company’s audited consolidated financial statements for the years ended December 31, 2025 and 2024 and their accompanying notes. The accompanying unaudited condensed consolidated interim financial statements are expressed in United States dollars (“USD”). In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of financial position and results of operations for the interim periods presented have been reflected herein. Operating results for the interim periods presented herein are not necessarily indicative of the results that may be expected for the year ending December 31, 2026. The Company’s fiscal year-end is December 31. The unaudited condensed consolidated interim financial statements include the accounts of the Company and its wholly owned subsidiary. Significant intercompany accounts and transactions have been eliminated.

Significant accounting estimates and assumptions The preparation of the unaudited condensed consolidated interim financial statements requires the use of estimates and assumptions to be made in applying the accounting policies that affect the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities. The estimates and related assumptions are based on previous experiences and other factors considered reasonable under the circumstances, the results of which form the basis for making the assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods. Significant accounts that require estimates include promissory notes, convertible notes and senior secured notes due to the use of discount rates. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Fair value of equity classified conversion feature and warrants</td></tr> </table> In determining the fair values of the equity classified conversion feature and warrants pursuant to debt financing transactions, the Company applies a market-based valuation technique using the most recent private placement price as a proxy for fair value. This valuation approach is considered a Level 3 fair value measurement within the fair value hierarchy due to the use of unobservable inputs. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Provisions</td></tr> </table> Provisions are recognized when the Company has a present obligation, legal or constructive, as a result of a previous event, if it is probable that the Company will be required to settle the obligation and a reliable estimate can be made of the obligation. The amount recognized is the best estimate of the expenditure required to settle the present obligation at the end of the reporting period, taking into account the risks and uncertainties surrounding the obligations. Provisions are reviewed at the end of each reporting period and adjusted to reflect the current best estimate of the expected future cash flows. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Contingencies</td></tr> </table> Contingencies can be either possible assets or possible liabilities arising from past events, which, by their nature, will be resolved only when one or more uncertain future events occur or fail to occur. The assessment of the existence and potential impact of contingencies inherently involves the exercise of significant judgment and the use of estimates regarding the outcome of future events. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Going concern</td></tr> </table> The Company evaluates its ability to continue as a going concern in accordance with ASC 205-40, Presentation of Financial Statements – Going Concern. This assessment requires significant judgment and involves the evaluation of relevant conditions and events that are known or reasonably knowable at the date the financial statements are issued, including the Company’s current financial condition, obligations due within one year, expected future cash flows, access to capital, and management’s plans. The assessment involves inherent uncertainty, as it requires management to project future conditions and the effectiveness of any plans intended to address potential liquidity shortfalls. If substantial doubt about the Company’s ability to continue as a going concern is identified, management evaluates whether its plans will mitigate that doubt, and appropriate disclosures are made in the financial statements.

Consolidation The accompanying unaudited condensed consolidated interim financial statements include the accounts of our wholly owned subsidiary, Blockchain.tv, Inc., which is dormant has not had operations since its inception. The functional and reporting currency of the Company and its subsidiaries are U.S. Dollar.

Segment reporting Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and assessing performance. We identified our Chief Executive Officer as the chief operating decision maker. We operate in one operating segment. Our operating decision maker allocates resources and assesses performance at the consolidated level.

Fair Value of Financial Instruments ASC 820 defines fair value, establishes a framework for measuring fair value and expands required disclosure about fair value measurements of assets and liabilities. ASC 820-10 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820-10 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: ● Level 1 – Valuation based on quoted market prices in active markets for identical assets or liabilities. ● Level 2 – Valuation based on quoted market prices for similar assets and liabilities in active markets. ● Level 3 – Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management’s best estimate of what market participants would use as fair value. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability. Fair value estimates presented herein are based on market assumptions and information available to management as of the reporting date. The carrying amounts of certain financial instruments approximate their fair values due to their short-term maturities or because their stated interest rates approximate market rates. These instruments include accounts payable and accrued expenses, interest payable on senior secured notes, promissory notes, convertible notes and senior secured notes.

Convertible notes and other debt instruments In connection with the issuance of promissory and convertible notes, in certain instances we issued common share purchase warrants (the “Warrants”) that entitle the holder to purchase shares of our Common Stock at a specified fixed exercise price at any time within a time period specified within each Warrant. We evaluated the embedded conversion feature, if any, and the warrants and concluded that they qualified as equity instruments under Accounting Standards Codification (ASC) 815, Derivatives and Hedging, and ASC 815-40, Contracts in Entity’s Own Equity. The fair value of the Warrants were separated from the promissory and convertible notes and accounted for as a reduction of the carrying amount of the note with an increase to additional paid-in capital. With respect to the embedded conversion features in the senior secured notes, although they qualify as derivatives under ASC 815, the Company concluded that no reliable basis exists to determine their fair value as of the reporting date. Accordingly, no value has been assigned to the conversion features, and the derivative liability recognized pertains solely to the freestanding warrants. The fair value of the Warrants that represented a discount was amortized and included in the consolidated statements of operation over the term of each note using the effective interest method.

Series A and C Convertible Preferred Stock The Series A and C convertible preferred stock (“Series A Preferred Stock” and “Series C Preferred Stock”) were accounted for as mezzanine equity.

Loss per share Net Loss Per Share The Company has adopted the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 260-10 which provides for calculation of “basic” and “diluted” earnings per share. Basic loss per share of common stock is computed by dividing net loss $660,455 [2025 - $709,477] from continuing operation by the weighted average number of shares of common stock 1,678,095,243 [2025 - 1,603,095,243], outstanding during the period. Diluted loss per share of common stock is computed similarly to basic loss per share from continuing operations except the weighted average shares outstanding are increased to include additional shares from the assumed exercise of any common stock equivalents, if dilutive.

660455

709477

1678095243

1603095243

Related Party Transactions We follow FASB ASC subtopic 850-10, “Related Party Transactions”, for the identification of related parties and disclosure of related party transactions. Pursuant to ASC 850-10-20, related parties include: a) our affiliates; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) our principal owners; e) our management; f) other parties with which we may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. Material related party transactions are required to be disclosed in the consolidated financial statements, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which statements of operation are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which statements of operations are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Income taxes The Company accounts for income taxes in accordance with ASC 740. The Company provides for Federal, State and Provincial income taxes payable, as well as for those deferred because of the timing differences between reporting income and expenses for consolidated financial statement purposes versus tax purposes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recoverable or settled. The effect of a change in tax rates is recognized as income or expense in the period of the change. A valuation allowance is established, when necessary, to reduce deferred income tax assets to the amount that is more likely than not to be realized.

Recently Issued Accounting Pronouncements Accounting guidance recently adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”) to improve the disclosures regarding a public entity’s reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The Company is required to adopt the guidance in the fourth quarter of fiscal 2025, though early adoption is permitted. The Company adopted quarterly requirements of this guidance beginning in the first quarter of 2025 and the adoption has no material impact on the unaudited condensed interim consolidated financial statements. New accounting guidance not yet adopted In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures (“ASU 2023-09”) to provide disaggregated income tax disclosures on rate reconciliation and income taxes paid. The Company is required to adopt the guidance in the fourth quarter of fiscal 2026, though early adoption is permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements. In January 2025, the FASB issued a clarification by ASU 2025-01 Income Statement - Expense Disaggregation Disclosures (Topic 220): A new guidance related to expense disaggregation disclosures. This guidance requires additional disclosure of certain amounts included in the expense captions presented in the Statement of Income as well as disclosures about selling expenses. The new guidance will be effective for us beginning in 2027 on an annual basis and in the first quarter of 2028 on a quarterly basis and may be applied on either a prospective or retrospective basis. Early adoption of the guidance is permitted. The Company is currently evaluating the effect this new guidance will have on our disclosures. The Company continues to evaluate the impact of the new accounting pronouncement, including enhanced disclosure requirements, on our business processes, controls and systems.

Note 4 Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities as of March 31, 2026 and December 31, 2025 are summarized below: Schedule of Accounts Payable and Accrued Liabilities <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260331_zTWtbZe9dvWk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20251231_zxwJWfKY8UHa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--AccountsPayableCurrent_iI_zyv3zvd70fn" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: justify">Accounts payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">519,661</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">645,386</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iI_z8tTXjNExCx4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accrued expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">267,422</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">272,422</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--AccruedInterestCurrent_iI_zdIhZsAuRWi3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Accrued interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,192,632</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,980,507</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_c20260331_zKrm3mYmc477" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">3,979,715</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_c20251231_zFODuguQMRw5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">3,898,315</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Schedule of Accounts Payable and Accrued Liabilities <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260331_zTWtbZe9dvWk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20251231_zxwJWfKY8UHa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--AccountsPayableCurrent_iI_zyv3zvd70fn" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: justify">Accounts payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">519,661</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">645,386</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iI_z8tTXjNExCx4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accrued expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">267,422</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">272,422</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--AccruedInterestCurrent_iI_zdIhZsAuRWi3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Accrued interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,192,632</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,980,507</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_c20260331_zKrm3mYmc477" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">3,979,715</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_c20251231_zFODuguQMRw5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">3,898,315</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

519661

645386

267422

272422

3192632 2980507

3979715

3898315

Note 5 Promissory Notes During the years ended December 31, 2021, 2022 and 2023, the Company issued several promissory notes with warrants. The Company evaluated the warrants and concluded that those warrants qualified as equity instruments under Accounting Standards Codification (ASC) 815, Derivatives and Hedging, and ASC 815-40, Contracts in Entity’s Own Equity. Due to the limited trading activity and pricing transparency of the Company’s Common Stock, observable market inputs for valuing the warrants were determined to be unreliable. Specifically: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company’s Common Stock is listed on the OTC Expert Market, which restricts public quotation and limits visibility to investors.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The average daily trading volume of the Company’s Common Stock is approximately $1,000, and the share price has historically been highly volatile in its thinly traded status.</td></tr> </table> Due to these limitations, valuation techniques that depend on quoted market prices cannot be reliably applied. Accordingly, the Company applied a market-based valuation technique using the most recent private placement price of $0.018 per share (dated November 2, 2021) as a proxy for fair value. This valuation approach is considered a Level 3 fair value measurement within the fair value hierarchy due to the use of unobservable inputs. The fair value of the freestanding warrants as of the reporting date was estimated based on this Level 3 input, and the corresponding equity classified warrants has been recorded under additional paid-in capital. Management believes this approach provides the most reasonable estimate of fair value in the absence of observable market data. Significant unobservable input used in the valuation was the private placement price of $0.018/share. No sensitivity analysis is presented due to the absence of a reliable market range of inputs. Promissory note issued during year ended December 31, 2021 On December 28, 2021, the Company issued a promissory note with a principal amount and cash proceeds of $500,000. The promissory note accrued interest at an annual rate of 12%. Upon the occurrence of an event of default, the promissory note accrued default interest at an annual rate of 15%. The promissory note matured on April 5, 2022. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $33,288 and $33,288, respectively, in the condensed consolidated interim statements of operations. As of March 31, 2026 and December 31, 2025, $500,000 in principal was outstanding. Promissory notes issued during year ended December 31, 2022 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">(a)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On January 14, 2022, the Company issued a promissory note with a principal amount and cash proceeds of $165,000. The promissory note required a $15,000 fee payment on maturity date.</td></tr> </table> The promissory note accrued interest at an annual rate of 10%. Upon the occurrence of an event of default, the promissory note accrued default interest at an annual rate of 15%. The convertible note matured on February 14, 2022. The fee payable of $15,000 was amortized to consolidated statements of operation over the term of the promissory note. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $10,171 and $10,171, respectively, in the condensed consolidated interim statements of operations. As of March 31, 2026 and December 31, 2025, $165,000 in principal was outstanding. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">(b)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On January 14, 2022, the Company issued a promissory note with a principal amount and cash proceeds of $150,000. The promissory note required a $15,000 fee payment on maturity date. The promissory note accrued interest at an annual rate of 10%. Upon the occurrence of an event of default, the promissory note accrued default interest at an annual rate of 15%. The convertible note matured on December 31, 2022.</td></tr> </table> The fee payable of $15,000 was amortized to consolidated statements of operations over the term of the promissory note. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $9,247 and $9,247, respectively, in the condensed consolidated interim statements of operations. As of March 31, 2026 and December 31, 2025, $150,000 in principal was outstanding. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">(c)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On April 27, 2022, the Company issued a promissory note with a principal amount of $125,000 for cash proceeds of $112,500. Upon the occurrence of an event of default, the promissory note accrued default interest at an annual rate of 20%. The promissory note matured on December 31, 2022.</td></tr> </table> For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $6,164 and $6,164, respectively, in the condensed consolidated interim statements of operations. As of March 31, 2026 and December 31, 2025, $125,000 in principal was outstanding. Promissory notes issued during year ended December 31, 2023 In February 2023, the Company issued a promissory note $44,950 to a third party that is non-interest bearing, unsecured and repayable on demand. On February 3, 2023, the Company entered into a securities purchase agreement with a lender pursuant to which the Company borrowed $88,760 and issued a promissory note that accrues interest a 12% per annum and is repayable in 10 monthly instalments starting March 15, 2023. As of December 31, 2023, the outstanding balance was $79,884, which was in default for failure to make required payments. Upon the occurrence of an event of default, the promissory note accrued default interest at an annual rate of 22% and is convertible into the Company’s Common Stock at a conversion price equal to 75% multiplied by the lowest trading price for the Common Stock during the ten trading days prior to the conversion date. The lender may not hold more than 4.99% of the Company’s outstanding Common Stock. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $6,697 and $6,697, respectively, in the condensed consolidated interim statements of operations.

500000

0.12

0.15

33288

500000 500000

165000

15000

0.10

0.15 15000

10171

165000

150000

15000 0.10 0.15 15000

9247

150000

125000

112500

0.20

6164

125000

44950

88760

0.12

79884

0.22

6697

Note 6 Convertible Notes During the years ended December 31, 2021, 2022 and 2023, the Company issued several series of unsecured convertible notes with embedded conversion features and freestanding warrants. The Company evaluated the embedded conversion features and the warrants and concluded that they qualified as equity instruments under Accounting Standards Codification (ASC) 815, Derivatives and Hedging, and ASC 815-40, Contracts in Entity’s Own Equity. Due to the limited trading activity and pricing transparency of the Company’s Common Stock, observable market inputs for valuing those instruments were determined to be unreliable. Specifically: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company’s Common Stock is listed on the OTC Expert Market, which restricts public quotation and limits visibility to investors.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The average daily trading volume of the Company’s Common Stock is approximately $1,000, and the share price has historically been highly volatile in its thinly traded status.</td></tr> </table> Accordingly, the Company applied a market-based valuation technique using the most recent private placement price of $0.018 per share (dated November 2, 2021) as a proxy for fair value. This valuation approach is considered a Level 3 fair value measurement within the fair value hierarchy due to the use of unobservable inputs. The fair value of the freestanding warrants as of the reporting date was estimated based on this Level 3 input, and the corresponding equity classified warrants has been recorded under additional paid-in capital. Management believes this approach provides the most reasonable estimate of fair value in the absence of observable market data. Significant unobservable input used in the valuation was the private placement price of $0.018/share. No sensitivity analysis is presented due to the absence of a reliable market range of inputs. Although the embedded conversion features meet the definition of equity classified instruments under ASC 815, the Company concluded that there is no reliable basis to estimate their fair value as of the reporting date. The features are highly sensitive to changes in various unobservable inputs, and due to the lack of active trading, volatility benchmarks, or comparable market data, any valuation would be purely speculative. Management assessed whether a Level 3 fair value estimate (e.g., using an option pricing model) could be developed, but concluded that input assumptions such as volatility and market-based discount rates were not supportable. As such, no value has been assigned to the embedded conversion features, and the recognized equity classified instruments pertains solely to the freestanding warrants. The Company will reassess the valuation of the conversion features in subsequent periods as market data becomes available. Our convertible notes payable, all of which are liabilities as of March 31, 2026 and December 31, 2025, are as follows: Schedule of convertible notes payable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260331_zbiMSY87qIVl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20251231_zK1a6vKnLiyl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesOneMember_zEkVrBE7r4W" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: justify">Series 1</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,050,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,050,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesTwoMember_zrWpQlr2kjie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Series 2</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">470,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">470,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesThreeMember_zJpBA2hsJKuj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Series 3</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesFourMember_zVe9QPx0oSx1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Series 4</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">220,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">220,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesFiveMember_z1HFdEbvILqa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Series 5</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">522,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">542,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesSixMember_zyAkUBU8OsGe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Series 6</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">55,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">55,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConvertibleNotesPayable_iI_z3cmVSa94rJ7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Principal outstanding total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,525,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,545,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ConvertibleNotesPayableCurrent_iI_zxcFXwvH1eV6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Less discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Principal outstanding, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20260331_zfnSBqWhpIQd" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal outstanding, net">2,525,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20251231_zBxcTvKfOMe1" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal outstanding, net">2,545,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Series 1 During the years ended December 31, 2021 and 2022, the Company issued convertible notes totaling $950,000 and $100,000, respectively. Convertible notes issued during year ended December 31, 2021 Series 1-1 On August 31, 2021, the Company issued a series of convertible notes with total principal amount and cash proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20210801__20210831__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesOneOneMember_zXhkSYuq1tg1" title="Cash Proceeds from convertible notes payable">950,000. Those convertible notes accrued interest at an annual rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20210831__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesOneOneMember_zrLmlhjHhfXa" title="Interest rate, percentage">6%. Upon the occurrence of an event of default, those convertible notes accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20210831__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesOneOneMember_z4IwB23uuxO2" title="Debt instrument unpaid principal default interest rate">12%. Those convertible notes matured on December 31, 2022. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_90A_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestOneMember__dei--LegalEntityAxis__custom--SeriesOneOneMember_znfDFZxHzQgj" title="Interest expense">42,166 and $<span id="xdx_904_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestOneMember__dei--LegalEntityAxis__custom--SeriesOneOneMember_zcmgXZvOjyk6" title="Interest expense">42,166 respectively, in the condensed consolidated interim statements of operations. Convertible notes issued during year ended December 31, 2022 Series 1-2 On April 5, 2022, the Company issued a convertible note with total principal amount and cash proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20220401__20220405__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesOneTwoMember_zzuFcGc4hXTj" title="Cash Proceeds from convertible notes payable">100,000. The convertible note accrued interest at an annual rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20220405__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesOneTwoMember_z714Q0Hq6Cx7" title="Interest rate, percentage">6%. Upon the occurrence of an event of default, the convertible note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20220405__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesOneTwoMember_zWU7a0Vd2BAi" title="Debt instrument unpaid principal default interest rate">12%. The convertible note matured on December 31, 2022. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_90C_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestOneMember__dei--LegalEntityAxis__custom--SeriesOneTwoMember_zofvHCYdT98f" title="Interest expense">4,439 and $<span id="xdx_905_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestOneMember__dei--LegalEntityAxis__custom--SeriesOneTwoMember_zr8JxCiO0Meh" title="Interest expense">4,439 respectively, in the condensed consolidated interim statements of operations. Series 2 Convertible notes issued during year ended December 31, 2022 Series 2-1 On January 5, 2022, the Company issued a convertible note with a principal amount and cash proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20220101__20220105__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesTwoOneMember_zJP2hb0460G5" title="Cash Proceeds from convertible notes payable">250,000. The convertible note accrued interest at an annual rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20220105__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesTwoOneMember_zCBvnjuYzNMi" title="Interest rate, percentage">12%. Upon the occurrence of an event of default, the note accrued default interest at an annual rate of <span id="xdx_904_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20220105__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesTwoOneMember_zeT5Ck3aYrHh" title="Debt instrument unpaid principal default interest rate">15%. The convertible note matured on April 5, 2022. As of December 31, 2022, the discount was fully amortized. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_903_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestTwoMember__dei--LegalEntityAxis__custom--SeriesTwoOneMember_zjFuAZRxYGMd" title="Interest expense">16,644 and $<span id="xdx_908_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestTwoMember__dei--LegalEntityAxis__custom--SeriesTwoOneMember_zTQ68m6lRdrb" title="Interest expense">16,644 respectively, in the condensed consolidated interim statements of operations. Convertible notes issued during year ended December 31, 2023 Series 2-4 On January 10, 2023, the Company issued a convertible note with a principal amount of $<span id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_c20230110__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesTwoFourMember_zg5Ft22fMARh" title="Principal amount, convertible note">110,000 for cash proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20230101__20230110__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesTwoFourMember_zfB6WcQ6ZNla" title="Cash Proceeds from convertible notes payable">100,000. The convertible note accrued interest at an annual rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20230110__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesTwoFourMember_zoPGixDqgEp3" title="Interest rate, percentage">12%. Upon the occurrence of an event of default, the convertible note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20230110__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesTwoFourMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zUp7fujUIG2c" title="Debt instrument unpaid principal default interest rate">22%. The convertible note matured on January 10, 2024. In connection with the issuance of the convertible note, the Company also issued common share purchase warrants that entitle the holder to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20230110__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesTwoFourMember_zbvcRjcSWFlc">20,000,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230110__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesTwoFourMember_z8veMybNJy3h" title="Common stock, exercise price">0.020 per share at any time until January 30, 2030. The fair values of the warrants of $<span id="xdx_903_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230110__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesTwoFourMember_zSVkqrKlpau4" title="Fair value of warrants">87,675 were separated from the convertible note and accounted for as a reduction of the carrying amount of the convertible note with an increase to additional paid-in capital. The issuance of the convertible note resulted in an original issuance discount of $10,000, calculated as the difference between the principal amount and the cash proceeds. The total of the original issuance discount and the allocated fair value of the warrants were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_903_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestTwoMember__dei--LegalEntityAxis__custom--SeriesTwoFourMember_zE596etxOb7a" title="Interest expense">9,221 and $9,221, respectively, in the condensed consolidated interim statements of operations. Series 2-5 On January 10, 2023, the Company issued a convertible note with a principal amount and cash proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20230101__20230110__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesTwoFiveMember_zd1Y0yXsjra1" title="Cash Proceeds from convertible notes payable">110,000. The convertible note accrued interest at an annual rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20230110__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesTwoFiveMember_z8BPL0R97ike" title="Interest rate, percentage">12%. Upon the occurrence of an event of default, the note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20230110__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesTwoFiveMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zF39h3DKnRij" title="Debt instrument unpaid principal default interest rate">22%. The convertible note matured on January 10, 2024. The note is in default. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_905_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestTwoMember__dei--LegalEntityAxis__custom--SeriesTwoFiveMember_zkUCXeMetcqe" title="Interest expense">9,221 and $<span id="xdx_908_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestTwoMember__dei--LegalEntityAxis__custom--SeriesTwoFiveMember_z4zyvXk17omc" title="Interest expense">9,221, respectively, in the condensed consolidated interim statements of operations. Series 3 Convertible notes issued during year ended December 31, 2022 Series 3-1 On February 11, 2022, the Company issued a convertible note with a principal amount of $<span id="xdx_905_eus-gaap--ConvertibleNotesPayable_iI_c20220211__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesThreeOneMember_zDY5RpSff0bk" title="Principal amount, convertible note">137,500 for cash proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20220201__20220211__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesThreeOneMember_zpzGlXZO5lYk" title="Cash Proceeds from convertible notes payable">125,000. The convertible note accrued interest at an annual rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20220211__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesThreeOneMember_zG78Gt3tMOjc" title="Interest rate, percentage">11.25%. Upon the occurrence of an event of default, the convertible note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20220211__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesThreeOneMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zVeGdXfN2lyd" title="Debt instrument unpaid principal default interest rate">22%. The convertible note matured on February 11, 2023. In connection with the issuance of the convertible note, the Company also issued common share purchase warrants (the “Warrants”) that entitle the holder to purchase <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20220211__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesThreeOneMember_zMW51Ymh5fxf">1,250,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220211__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesThreeOneMember_z6yrjwqu0ca4" title="Common stock, exercise price">0.10 per share at any time until February 11, 2027. The fair values of the warrants of $<span id="xdx_902_eus-gaap--FairValueAdjustmentOfWarrants_c20220201__20220211__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesThreeOneMember_zOZb1F9JrdF" title="Fair value of warrants">22,568 were separated from the convertible note and accounted for as a reduction of the carrying amount of the convertible note with an increase to additional paid-in capital. The issuance of the convertible note resulted in an original issuance discount of $12,500, calculated as the difference between the principal amount and the cash proceeds. The total of the original issuance discount and the allocated fair value of the warrants were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_906_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestThreeMember__dei--LegalEntityAxis__custom--SeriesThreeOneMember_znIJjF0rVLNj" title="Interest expense">7,639 and $7,639 in the condensed consolidated interim statements of operations. Series 3-2 On February 11, 2022, the Company issued a convertible note with a principal amount of $<span id="xdx_902_eus-gaap--ConvertibleNotesPayable_iI_c20220211__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesThreeTwoMember_zFzWp19D0pVh" title="Principal amount, convertible note">137,500 for cash proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20220201__20220211__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesThreeTwoMember_zNjWidmToICh" title="Cash Proceeds from convertible notes payable">125,000. The convertible note accrued interest at an annual rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20220211__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesThreeTwoMember_zAea1SqU2WDg" title="Interest rate, percentage">11%. Upon the occurrence of an event of default, the convertible note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20220211__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesThreeTwoMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zmPztYquK0Vf" title="Debt instrument unpaid principal default interest rate">15%. The convertible note matured on February 18, 2023. In connection with the issuance of the convertible note, the Company also issued common share purchase warrants (the “Warrants”) that entitle the holder to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20220211__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesThreeTwoMember_zD4O4YjowBJj">1,250,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220211__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesThreeTwoMember_zRyc4KWtjQX9" title="Common stock, exercise price">0.10 per share at any time until February 11, 2027. The fair values of the warrants of $<span id="xdx_904_eus-gaap--FairValueAdjustmentOfWarrants_c20220201__20220211__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesThreeTwoMember_zJZQPCvbmiE5" title="Fair value of warrants">22,568 were separated from the convertible note and accounted for as a reduction of the carrying amount of the convertible note with an increase to additional paid-in capital. The issuance of the convertible note resulted in an original issuance discount of $12,500, calculated as the difference between the principal amount and the cash proceeds. The total of the original issuance discount and the allocated fair value of the warrants were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_906_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestThreeMember__dei--LegalEntityAxis__custom--SeriesThreeTwoMember_zsqWO6e8J4i4" title="Interest expense">11,274 and $<span id="xdx_90B_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestThreeMember__dei--LegalEntityAxis__custom--SeriesThreeTwoMember_zbUPkRWoLEji" title="Interest expense">11,274 in the condensed consolidated interim statements of operations. Series 4 Convertible notes issued during year ended December 31, 2022 Series 4-1 On May 5, 2022, the Company issued a secured convertible note with a principal amount of $<span id="xdx_90B_eus-gaap--ConvertibleNotesPayable_iI_c20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFourOneMember_z1LDmzGiH5v8" title="Principal amount, convertible note">110,000 for cash proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20220401__20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFourOneMember_zAftcx5RCQIb" title="Cash Proceeds from convertible notes payable">100,000. The secured convertible note accrued interest at an annual rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFourOneMember_z6sBR97WUBU" title="Interest rate, percentage">12%. Upon the occurrence of an event of default, the convertible note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFourOneMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zWIjdOJ3v0tf" title="Debt instrument unpaid principal default interest rate">22%. The convertible note matured on May 5, 2023. The note is subordinated to the Investor’s Senior Secured Notes, but shall have priority in right of payment over, all of the Company’s non-senior indebtedness outstanding as of May 5, 2022 such in the event of any default, all sums payable for this secured note are subordinated in right of payment to the Investor’s Senior Secured Notes, but shall first be paid in full before any payment is made upon any other non-senior indebtedness. The secured convertible notes is secured by a subordinated blanket lien on the Company’s assets. In connection with the issuance of the convertible note, the Company also issued common share purchase warrants (the “Warrants”) that entitle the holder to purchase <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20220505__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFourOneMember_zDyR7GbJ70A">5,000,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220505__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFourOneMember_zmpiNqvv4cxl" title="Common stock, exercise price">0.02 per share at any time until May 5, 2029. The fair values of the warrants of $<span id="xdx_90D_eus-gaap--FairValueAdjustmentOfWarrants_c20220401__20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFourOneMember_zNB0Y9t0pzD" title="Fair value of warrants">54,495 were separated from the convertible note and accounted for as a reduction of the carrying amount of the convertible note with an increase to additional paid-in capital. The issuance of the convertible note resulted in an original issuance discount of $10,000, calculated as the difference between the principal amount and the cash proceeds. The total of the original issuance discount and the allocated fair value of the warrants were amortized to condensed consolidated interim statements of operations over the term of the convertible note using the effective interest method. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_903_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestFourMember__dei--LegalEntityAxis__custom--SeriesFourOneMember_zkvBRG7TTj78" title="Interest expense">9,221 and $<span id="xdx_904_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestFourMember__dei--LegalEntityAxis__custom--SeriesFourOneMember_zXN3nEYHoGm2" title="Interest expense">9,221 in the condensed consolidated interim statements of operations. Series 4-2 On June 24, 2022, the Company issued a convertible note with a principal amount of $<span id="xdx_90C_eus-gaap--ConvertibleNotesPayable_iI_c20220624__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFourTwoMember_zcsBjbxXbYq3" title="Principal amount, convertible note">110,000 for cash proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20220601__20220624__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFourTwoMember_zaBo8M0KXBM3" title="Cash Proceeds from convertible notes payable">100,000. The convertible note accrued interest at an annual rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20220624__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFourTwoMember_z7xNzWhxAFBb" title="Interest rate, percentage">12%. Upon the occurrence of an event of default, the convertible note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20220624__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFourTwoMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zOpBdHVD7Dn7" title="Debt instrument unpaid principal default interest rate">22%. The convertible note matured on May 5, 2023. In connection with the issuance of the convertible note, the Company also issued common share purchase warrants (the “Warrants”) that entitle the holder to purchase <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20220624__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFourTwoMember_zFvpQs4QcWp9">5,000,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220624__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFourMember_zhvaeKAR98pb" title="Common stock, exercise price">0.02 per share at any time until June 24, 2029. The fair values of the warrants of $<span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_c20220601__20220624__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFourTwoMember_zN2uivvqnsW" title="Fair value of warrants">54,111 were separated from the convertible note and accounted for as a reduction of the carrying amount of the convertible note with an increase to additional paid-in capital. The issuance of the convertible note resulted in an original issuance discount of $10,000, calculated as the difference between the principal amount and the cash proceeds. The total of the original issuance discount and the allocated fair value of the warrants were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_902_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestFourMember__dei--LegalEntityAxis__custom--SeriesFourTwoMember_zqihlxrsb2t6" title="Interest expense">9,221 and $<span id="xdx_908_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestFourMember__dei--LegalEntityAxis__custom--SeriesFourTwoMember_z3nkNeJVZVdg" title="Interest expense">9,221 in the condensed consolidated interim statements of operations. Series 5 Convertible notes issued during year ended December 31, 2022 Series 5-1 On May 5, 2022, the Company issued a convertible note with a principal amount of $<span id="xdx_906_eus-gaap--ConvertibleNotesPayable_iI_c20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveOneMember_zsXgIOoUPuq6" title="Principal amount, convertible note">82,500 for cash proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20220401__20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveOneMember_zs6Lwt5wNP9l" title="Cash Proceeds from convertible notes payable">75,000. The convertible note accrued interest at an annual rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveOneMember_zfiDlFcutd4e" title="Interest rate, percentage">12%. Upon the occurrence of an event of default, the convertible note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveOneMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zCVRGUKJZQk6" title="Debt instrument unpaid principal default interest rate">22%. The convertible note matured on May 5, 2023. In connection with the issuance of the convertible note, the Company also issued common share purchase warrants (the “Warrants”) that entitle the holder to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20220505__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFiveOneMember_zeeaMHKp5rF2">3,750,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220505__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFiveOneMember_zg8iPT6WlYjd" title="Common stock, exercise price">0.02 per share at any time until May 5, 2029. The fair values of the warrants of $<span id="xdx_908_eus-gaap--FairValueAdjustmentOfWarrants_c20220401__20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveOneMember_z2nziTvTbfde" title="Fair value of warrants">40,872 were separated from the convertible note and accounted for as a reduction of the carrying amount of the convertible note with an increase to additional paid-in capital. The issuance of the convertible note resulted in an original issuance discount of $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20220505__dei--LegalEntityAxis__custom--SeriesFiveOneMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember_z1s2ndy1gzK4" title="Original issuance discount">7,500, calculated as the difference between the principal amount and the cash proceeds. The total of the original issuance discount and the allocated fair value of the warrants were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_901_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestFiveMember__dei--LegalEntityAxis__custom--SeriesFiveOneMember_ziAVQ1pdOREk" title="Interest expense">6,917 and $<span id="xdx_903_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestFiveMember__dei--LegalEntityAxis__custom--SeriesFiveOneMember_zhQrWPFpQat9" title="Interest expense">6,917 in the condensed consolidated interim statements of operations. Series 5-2 On May 5, 2022, the Company issued a convertible note with a principal amount of $<span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_c20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveTwoMember_z5u9Fju4NHgf" title="Principal amount, convertible note">110,000 for cash proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20220401__20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveTwoMember_zux3FqN5jGi9" title="Cash Proceeds from convertible notes payable">100,000. The convertible note accrued interest at an annual rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveTwoMember_zOhLBmq0id24" title="Interest rate, percentage">11%. Upon the occurrence of an event of default, the convertible note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveTwoMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zRAQ0nCQTDQa" title="Debt instrument unpaid principal default interest rate">22%. The convertible note matured on May 5, 2023. In connection with the issuance of the convertible note, the Company also issued common share purchase warrants (the “Warrants”) that entitle the holder to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20220505__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFiveTwoMember_z82zkq1bEDN6">5,000,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220505__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFiveTwoMember_ztmfi3Y96Jhd" title="Common stock, exercise price">0.02 per share at any time until May 5, 2029. The fair values of the warrants of $<span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20220401__20220505__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveTwoMember_zkzK8MyzUGU3" title="Fair value of warrants">54,495 were separated from the convertible note and accounted for as a reduction of the carrying amount of the convertible note with an increase to additional paid-in capital. The issuance of the convertible note resulted in an original issuance discount of $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20220505__dei--LegalEntityAxis__custom--SeriesFiveTwoMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember_zgzyUxv4vDz4" title="Original issuance discount">10,000, calculated as the difference between the principal amount and the cash proceeds. The total of the original issuance discount and the allocated fair value of the warrants were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_900_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestFiveMember__dei--LegalEntityAxis__custom--SeriesFiveTwoMember_zSOUvpTvXVF1" title="Interest expense">9,017 and $<span id="xdx_909_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestFiveMember__dei--LegalEntityAxis__custom--SeriesFiveTwoMember_zaZ7RH5FiUSd" title="Interest expense">9,017 in the condensed consolidated interim statements of operations. Series 5-3 On October 14, 2022, the Company issued a convertible note with a principal amount of $<span id="xdx_906_eus-gaap--ConvertibleNotesPayable_iI_c20221014__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveThreeMember_ziy9FjviQcM3" title="Principal amount, convertible note">110,000 for cash proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20221001__20221014__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveThreeMember_ztfZ8rc694We" title="Cash Proceeds from convertible notes payable">110,000. The convertible note accrued interest at an annual rate of <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20221014__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveThreeMember_zv4saoxFeqki" title="Interest rate, percentage">12%. Upon the occurrence of an event of default, the convertible note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20221014__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveThreeMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zBD1QQDfOID9" title="Debt instrument unpaid principal default interest rate">22%. The convertible note matured on February 23, 2023. In connection with the issuance of the convertible note, the Company also issued common share purchase warrants (the “Warrants”) that entitle the holder to purchase <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20221014__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFiveThreeMember_zXWhKspsmT85">5,000,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20221014__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFiveThreeMember_zFdNkY50wcHl" title="Common stock, exercise price">0.02 per share at any time until May 5, 2029. The fair value of the warrants of $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_c20221001__20221014__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveThreeMember_zdYYaOB5aQYb" title="Fair value of warrants">51,262 were separated from the convertible note and accounted for as a reduction of the carrying amount of the convertible note with an increase to additional paid-in capital. The fair value of the warrants was amortized to consolidated statements of operations over the term of the convertible note using the effective interest method. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_905_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestFiveMember__dei--LegalEntityAxis__custom--SeriesFiveThreeMember_z324jgR7O7Vj" title="Interest expense">7,323 and $<span id="xdx_903_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestFiveMember__dei--LegalEntityAxis__custom--SeriesFiveThreeMember_zbiQj43Fh2Ig" title="Interest expense">7,323 in the condensed consolidated interim statements of operations. Series 5-4 On December 15, 2022, the Company issued a convertible note with a principal amount of $<span id="xdx_90A_eus-gaap--ConvertibleNotesPayable_iI_c20221215__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveFourMember_ztw64oVlGxNd" title="Principal amount, convertible note">220,000 for cash proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20221201__20221215__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveFourMember_zuX09Y73miF6" title="Cash Proceeds from convertible notes payable">200,000. The convertible note accrued interest at an annual rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20221215__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveFourMember_zaqg76rtP6K3" title="Interest rate, percentage">12%. Upon the occurrence of an event of default, the convertible note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20221215__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveFourMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_z28jhsm8YPo8" title="Debt instrument unpaid principal default interest rate">22%. The convertible note matured on January 10, 2024. In connection with the issuance of the convertible note, the Company also issued common share purchase warrants (the “Warrants”) that entitle the holder to purchase <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20221215__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFiveFourMember_z0VT5oUofBDi">10,000,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20221215__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember__dei--LegalEntityAxis__custom--SeriesFiveFourMember_za4BjX9WQXhf" title="Common stock, exercise price">0.02 per share at any time until May 5, 2029. The fair values of the warrants of $<span id="xdx_900_eus-gaap--FairValueAdjustmentOfWarrants_c20221201__20221215__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesFiveFourMember_zbqGek5ZM1Fj" title="Fair value of warrants">73,111 were separated from the convertible note and accounted for as a reduction of the carrying amount of the convertible note with an increase to additional paid-in capital. The issuance of the convertible note resulted in an original issuance discount of $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20221215__dei--LegalEntityAxis__custom--SeriesFiveFourMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember_zTYiprYgqRwk" title="Original issuance discount">20,000, calculated as the difference between the principal amount and the cash proceeds. The total of the original issuance discount and the allocated fair value of the warrants were being amortized to consolidated statements of operations over the term of the convertible note using the effective interest method. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_905_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestFiveMember__dei--LegalEntityAxis__custom--SeriesFiveFourMember_z8NhIBr3U0ol" title="Interest expense">18,444 and $<span id="xdx_906_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestFiveMember__dei--LegalEntityAxis__custom--SeriesFiveFourMember_zBiZLbgbJ2Mb" title="Interest expense">18,444 in the condensed consolidated interim statements of operations. Series 6 Convertible notes issued during year ended December 31, 2022 Series 6-1 On September 16, 2022, the Company issued a convertible note with a principal amount of $<span id="xdx_90B_eus-gaap--ConvertibleNotesPayable_iI_c20220916__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesSixOneMember_zRZAlNbQajXh" title="Principal amount, convertible note">55,000 for cash proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20220901__20220916__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesSixOneMember_zGqAeYFreGnd" title="Cash Proceeds from convertible notes payable">50,000. The convertible note accrued interest at an annual rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uRatio_c20220916__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesSixOneMember_zIJJIbDB78Zd" title="Interest rate, percentage">6% starting from January 1, 2023. Upon the occurrence of an event of default, the convertible note accrued default interest at an annual rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIENvbnZlcnRpYmxlIE5vdGVzIHBheWFibGUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_ecustom--DebtInstrumentUnpaidPrincipalDefaultInterestRate_iI_pid_dp_uRatio_c20220916__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember__dei--LegalEntityAxis__custom--SeriesSixOneMember__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zgmObq0IvCfk" title="Debt instrument unpaid principal default interest rate">12%. The convertible note matured on September 16, 2023. The original issuance discount of $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_iI_c20220916__dei--LegalEntityAxis__custom--SeriesSixOneMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredNotesPayableOneMember_zYl1GrQiURZe" title="Original issuance discount">5,000 and the fair value of the embedded conversion feature were amortized to consolidated statements of operations over the term of the convertible note using the effective interest method. For the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $<span id="xdx_900_eus-gaap--InterestExpense_c20260101__20260331__custom--StatementLineItemAxis__custom--OperatingInterestSixMember__dei--LegalEntityAxis__custom--SeriesSixOneMember_z8lQcdlblgk1" title="Interest expense">1,628 and $<span id="xdx_90A_eus-gaap--InterestExpense_c20250101__20250331__custom--StatementLineItemAxis__custom--OperatingInterestSixMember__dei--LegalEntityAxis__custom--SeriesSixOneMember_zWa0f0FFMHM8" title="Interest expense">1,628 in the consolidated statements of operations. 0.018

Our convertible notes payable, all of which are liabilities as of March 31, 2026 and December 31, 2025, are as follows: Schedule of convertible notes payable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260331_zbiMSY87qIVl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20251231_zK1a6vKnLiyl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesOneMember_zEkVrBE7r4W" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: justify">Series 1</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,050,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,050,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesTwoMember_zrWpQlr2kjie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Series 2</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">470,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">470,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesThreeMember_zJpBA2hsJKuj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Series 3</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesFourMember_zVe9QPx0oSx1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Series 4</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">220,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">220,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesFiveMember_z1HFdEbvILqa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Series 5</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">522,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">542,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ConvertibleNotesPayable_iI_hdei--LegalEntityAxis__custom--SeriesSixMember_zyAkUBU8OsGe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Series 6</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">55,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">55,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConvertibleNotesPayable_iI_z3cmVSa94rJ7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Principal outstanding total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,525,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,545,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ConvertibleNotesPayableCurrent_iI_zxcFXwvH1eV6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Less discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Principal outstanding, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20260331_zfnSBqWhpIQd" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal outstanding, net">2,525,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20251231_zBxcTvKfOMe1" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal outstanding, net">2,545,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1050000

470000

208000

220000

522500

542500

55000

2525500

2545500

2525500

2545500

950000

100000

950000

0.06

0.12

42166

100000

0.06

0.12

4439

250000

0.12

0.15

16644

110000

100000

0.12

0.22

20000000

0.020

87675

10000

9221

110000

0.12

0.22

9221

137500

125000

0.1125

0.22

1250000

0.10

22568

12500

7639

137500

125000

0.11

0.15

1250000

0.10

22568

12500

11274

110000

100000

0.12

0.22

5000000

0.02

54495

10000

9221

110000

100000

0.12

0.22

5000000

0.02

54111

10000

9221

82500

75000

0.12

0.22

3750000

0.02

40872

7500

6917

110000

100000

0.11

0.22

5000000

0.02

54495

10000

9017

110000

0.12

0.22

5000000

0.02

51262

7323

220000

200000

0.12

0.22

10000000

0.02

73111

20000

18444

55000

50000

0.06

0.12

5000

1628

Note 7 Senior Secured Notes On February 17, 2021, the Company entered into a securities purchase agreement with funds affiliated with Arena Investors, LP (the “Investors”) pursuant to which it issued two convertible notes having an aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20210217__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zK5Y8WWNfqOf" title="Aggregate principal amount of convertible notes">16,500,000 for an aggregate purchase price of $15,000,000 (collectively, the “Notes”). The Notes are secured by a blanket lien on all of the Company’s assets and the shares of the Company’s Common Stock and Preferred Stock (the “Pledged Assets”). In connection with the issuance of the Notes, the Company also issued <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20210217__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zhEswo3Oo4Qh" title="Number of common share purchase warrants issued">192,073,016 number of common share purchase warrants (the “Warrants”) and 1,000 Preferred Series F Shares to the investors (Note 10). The Notes would mature on February 17, 2024, unless earlier converted, and accrue interest at a rate of 11% per annum, subject to increase to 20% per annum upon the occurrence of an event of default. Interest is payable in cash on a quarterly basis, commencing on March 31, 2021. Conversion Feature The Notes contain conversion features that allow the Investors to convert the Notes and unpaid interests into shares of the Company’s common stock. On September 24, 2021, the Notes were amended to change the conversion price to $0.02. Warrants The Warrants entitle the Investors to purchase shares of the Company’s common stock. The exercise price may be paid on a cashless basis. On September 24, 2021, the exercise price of the Warrants was amended to $0.025. The Company evaluated the conversion feature and warrants in accordance with Accounting Standards Codification (ASC) 815, Derivatives and Hedging. Initially, the conversion features and warrants were determined to be derivative liabilities. However, as the Company’s common stock is quoted on the OTC Expert Market, which lacks sufficient trading volume and transparency, management determined that reliable market inputs necessary to support a fair value measurement were not available. As a result, the fair value of the embedded conversion features was assessed to be nil. The fair values of the warrants of $3,464,529 were separated from the note and accounted for as a reduction of the carrying amount of the note with a recognition of derivative liabilities). On September 24, 2021, upon the amendment of the exercise price of the warrants to a fixed price, the Company re-evaluated the amended terms in accordance with ASC 815-40 Contracts In Entity’s Own Equity, derecognized the derivative liabilities related to those warrants, and recognized the Warrants in equity (“End of derivative warrants treatment”). The issuance of the Notes resulted in an original issuance discount of $1,500,000. Additionally, the fair value of the Preferred Series F Shares issued in connection with the Notes issuance and the derivative liabilities recognized were $32,229 and $3,464,529 respectively. These amounts totalling $4,996,758 was recorded as a discount to the face value of the Notes. The discount was amortized to consolidated statements of operations over the term of the notes using the effective interest method. On February 1, 2023, pursuant to an agreement with the lender of the Company’s senior secured notes, Sovryn was sold to the lender. The net assets of Sovryn at the time of disposition totalled $9,159,907, which was used to partially settle the principal balance of the senior secured notes, which totalled $16,500,000. The transaction was accounted for as a non-cash settlement. Schedule of senior secured notes issued <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center">$</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 85%; text-align: left">Face value of senior secured notes issued</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--FaceValueOfSeniorSecuredNotesIssued_iI_c20211231_z4GbNC99fmMd" style="width: 12%; text-align: right" title="Face value of senior secured notes issued">16,500,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--DebtInstrumentsUnamortizedDiscount_iI_c20211231_z7SOEFRpnNR3" style="border-bottom: Black 1pt solid; text-align: right" title="Debt discount">(4,996,758</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Day 1 value of senior secured notes issued</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98B_ecustom--Day1ValueOfSeniorSecuredNotesIssued_iI_c20211231_zwD5VDuzVT7g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Day 1 value of senior secured notes issued">11,503,242</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Amortization expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210101__20211231_zDaIz62gEHQj" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization expenses">1,262,697</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 1pt">Balance at December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98E_ecustom--SeniorSecuredNotesNetOfDiscounts_iI_c20211231_zAmibNTAj834" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Senior Secured Notes Net Of Discount">12,765,939</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Amortization expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AdjustmentForAmortization_c20220101__20221231_zCkq428yGKOl" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization expenses">1,631,127</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1pt">Balance at December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_983_ecustom--SeniorSecuredNotesNetOfDiscounts_iI_c20221231_zD9GNnwqG9Nj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Senior Secured Notes Net Of Discount">14,397,066</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Partial settlement of principal</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--PartialSettlementOfPrincipal_iI_c20231231_zjLINgslfp9c" style="text-align: right" title="Partial settlement of principal">(9,159,907</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Amortization expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20230101__20231231_zvHGbfNDA6c2" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization expenses">1,987,011</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1pt">Balance at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_981_ecustom--SeniorSecuredNotesNetOfDiscounts_iI_c20231231_zmwSo1NitD14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Senior Secured Notes Net Of Discount">7,224,170</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Amortization expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AdjustmentForAmortization_c20240101__20241231_zDoLxq8lYCTe" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization expenses">115,923</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Balance at December 31, 2024</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_981_ecustom--SeniorSecuredNotesNetOfDiscounts_iI_c20241231_zEApaUFaHuOe" style="font-weight: bold; text-align: right" title="Senior Secured Notes Net Of Discount">7,340,093</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Amortization expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AdjustmentForAmortization_c20250101__20251231_zHh6k5akqOSl" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization expenses">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at December 31, 2025</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_985_ecustom--SeniorSecuredNotesNetOfDiscounts_iI_c20251231_zfHmN91Jfst6" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Senior Secured NotesNet Of Discount">7,340,093</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Senior Secured Notes (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> </table> The Company recorded interest expenses of $361,977 and $361,977 for the three months ended March 31, 2026 and 2025, respectively. The interest payable on senior secured notes as on March 31, 2026 and December 31, 2025 amounts to $8,228,889 and $7,866,912, respectively.

16500000

15000000

192073016

1000

0.11

0.20

0.02

0.025

1500000

32229

3464529

4996758

9159907

16500000

Schedule of senior secured notes issued <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center">$</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 85%; text-align: left">Face value of senior secured notes issued</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--FaceValueOfSeniorSecuredNotesIssued_iI_c20211231_z4GbNC99fmMd" style="width: 12%; text-align: right" title="Face value of senior secured notes issued">16,500,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--DebtInstrumentsUnamortizedDiscount_iI_c20211231_z7SOEFRpnNR3" style="border-bottom: Black 1pt solid; text-align: right" title="Debt discount">(4,996,758</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Day 1 value of senior secured notes issued</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98B_ecustom--Day1ValueOfSeniorSecuredNotesIssued_iI_c20211231_zwD5VDuzVT7g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Day 1 value of senior secured notes issued">11,503,242</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Amortization expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210101__20211231_zDaIz62gEHQj" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization expenses">1,262,697</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 1pt">Balance at December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98E_ecustom--SeniorSecuredNotesNetOfDiscounts_iI_c20211231_zAmibNTAj834" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Senior Secured Notes Net Of Discount">12,765,939</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Amortization expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AdjustmentForAmortization_c20220101__20221231_zCkq428yGKOl" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization expenses">1,631,127</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1pt">Balance at December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_983_ecustom--SeniorSecuredNotesNetOfDiscounts_iI_c20221231_zD9GNnwqG9Nj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Senior Secured Notes Net Of Discount">14,397,066</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Partial settlement of principal</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--PartialSettlementOfPrincipal_iI_c20231231_zjLINgslfp9c" style="text-align: right" title="Partial settlement of principal">(9,159,907</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Amortization expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20230101__20231231_zvHGbfNDA6c2" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization expenses">1,987,011</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1pt">Balance at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_981_ecustom--SeniorSecuredNotesNetOfDiscounts_iI_c20231231_zmwSo1NitD14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Senior Secured Notes Net Of Discount">7,224,170</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Amortization expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AdjustmentForAmortization_c20240101__20241231_zDoLxq8lYCTe" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization expenses">115,923</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Balance at December 31, 2024</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_981_ecustom--SeniorSecuredNotesNetOfDiscounts_iI_c20241231_zEApaUFaHuOe" style="font-weight: bold; text-align: right" title="Senior Secured Notes Net Of Discount">7,340,093</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Amortization expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AdjustmentForAmortization_c20250101__20251231_zHh6k5akqOSl" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization expenses">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at December 31, 2025</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_985_ecustom--SeniorSecuredNotesNetOfDiscounts_iI_c20251231_zfHmN91Jfst6" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Senior Secured NotesNet Of Discount">7,340,093</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Senior Secured Notes (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> </table> 16500000 -4996758 11503242

1262697

12765939

1631127

14397066 -9159907

1987011

7224170

115923

7340093 7340093

361977

8228889 7866912

Note 8 Related Party As at March 31, 2026 and December 31, 2025, respectively, $923,014 and $725,582 was due to principal shareholder. This amounts were received to support the Company’s working capital requirement, and it is unsecured, non-interest bearing and payable on demand.

923014

725582

Note 9 Stockholders’ Deficiency Preferred Stock As of March 31, 2026 and December 31, 2025, the Company is authorized to issue 50,000,000 shares of preferred stock, with designations, voting, and other rights and preferences to be determined by our Board of Directors, of which 48,460,905 remain available for designation and issuance. Series A Preferred Stock and Series B Preferred Stock On July 28, 2020, the Company filed a certificate of designations of Series A Convertible Preferred Stock (the “Certificate of Designations”) with the Nevada Secretary of State designating <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20200728__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ziEgMcE8auBf" title="Preferred stock, shares authorized">100,000 shares of the Company’s shares of Preferred Stock as Series A Convertible Preferred Stock and setting forth the voting and other powers, preferences and relative, participating, optional or other rights of the Preferred Shares. Each share of Series A Preferred Stock has a par value of $0.001 per share and a stated value of $100 per share. Holders of the Series A Preferred Stock are entitled to vote on all matters submitted to the Company’s shareholders, with their voting power equivalent to the number of Common Stock shares they would hold if their preferred stock were converted. This voting right can be exercised through written consent or proxy. The Series A Preferred Stock does not have redemption rights. The Series A Preferred Stock, with respect to the payment of dividends and payments upon the liquidation of the Company, ranks senior to all capital stock of the Company. The Series A Preferred Stockholders is entitled to receive cumulative quarterly dividends, payable in additional Series A Preferred Stock, at an annual rate of 3% of the Stated Value, when declared by the Board. The Board did not declare dividend since issuance of the Series A Preferred Shares. The Series A Preferred Stock is convertible by the holder into <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20200701__20200728__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zWCz16FpKvxl">3,420 shares of the Company’s Common Stock at any time after issuance. For the 24 months following issuance, the conversion ratio will be adjusted if the Company issues Common Stock (or related securities) that causes the total fully diluted Common Stock outstanding to exceed 360,000,000 shares. The adjusted conversion ratio will be calculated based on the total fully diluted shares after such issuance divided by 360,000,000, multiplied by the current conversion ratio. In the event of a liquidation, dissolution, or winding up of the Company, or a Sale (defined as a sale of the majority of assets or certain mergers/consolidations), holders of Series A Preferred Stock are entitled to receive, prior to any distribution to junior securities, an amount equal to the Stated Value plus all accrued and unpaid dividends. If the Company’s assets are insufficient to pay this full amount, the remaining assets will be distributed proportionally among the Series A Preferred stockholders. The Company will provide at least 45 days’ written notice of any such Liquidation. The number of Series A Preferred Stock issued and outstanding as of March 31, 2026 and December 31, 2025 was <span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dxL_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z2glNYzVFTlj" title="Series A Preferred Stock Outstanding::XDX::0"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dxL_uShares_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zePNB5THZrmk" title="Series A Preferred Stock Outstanding::XDX::0">Nil. On July 28, 2020, the Company filed a certificate of designations of Series B Super Voting Preferred Stock (the “Certificate of Designations”) with the Nevada Secretary of State designating <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20200728__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zB8fMi65x0Wg" title="Preferred stock, shares authorized">100 shares of the Company’s shares of Preferred Stock as Series B Super Voting Preferred Stock and setting forth the voting and other powers, preferences and relative, participating, optional or other rights of the Preferred Shares. Each share of Series B Preferred Stock has a par value of $0.001 per share. The shares of Series B Super Voting Preferred Stock will carry a number of votes equal to 51% (representing majority voting power) of all voting shares of every class, including 51% of all of the issued and outstanding shares of common stock on the date of any shareholder vote, such that the holders of Super Voting Preferred Stock shall always possess the majority of voting rights, and shall always out vote all holders of Common Stock. The Series B Preferred Stock does not have redemption rights. The Series B Preferred Stock will not be entitled to dividends unless the Corporation pays cash dividends or dividends in other property to holders of outstanding shares of Common Stock. There is no mandatory conversion of Series B Super Voting Preferred Stock into Common Stock. On February 17, 2021, the <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20210217__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zVO8ylUTqmch">100 shares Series B Preferred Stock were transferred from Mr. Canouse (the Company’s former director and CEO), to the FFO 1 2021 Irrevocable Trust, a company that Mr. Falcone (the Company’s former director and CEO) is the trustee and has the voting and dispositive power. The 100 shares of Series B Preferred are included in the collateral for the Investor Notes. In July 2020, pursuant to an acquisition agreement to acquire the Casa Zeta-Jones Brand License Agreement from Luxurie Legs, LLC, the Company issued <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_uShares_c20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember_z6Z27Fuxlis9">92,999 shares of Series A Preferred Stock and <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_uShares_c20200701__20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember_z35OW3Oomy67">100 shares of Series B Preferred Stock. The fair values of the Series A and Series B Preferred Stock issued were $<span id="xdx_90D_eus-gaap--StockIssued1_uUSD_c20200701__20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zrAsxpVKatMf" title="Fair value of series A preferred stock issued">216,150 and $<span id="xdx_90A_eus-gaap--StockIssued1_uUSD_c20200701__20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zpQOi3u633vi" title="Fair value of series B preferred stock issued">47,553, respectively, and were determined using a discounted cash flow method. The Company recognized an intangible asset as a result of this share issuance. The Company accounted for its Series A Preferred Stock as Mezzanine Equity in accordance with ASC 480, Distinguishing Liabilities from Equity. The embedded conversion feature of the preferred stock was evaluated under ASC 815, Derivatives and Hedging, and was separated from the host instrument. This embedded conversion feature was recognized as a derivative liability, with changes in its fair value recorded in the consolidated statements of operations at each reporting period end. Upon the issuance of the Series A Preferred Stock, the Company recognized derivative liabilities of $58,545. For the year ended December 31, 2020, a gain of $20,657 resulting from the change in the fair value of these derivative liabilities was recognized in the consolidated statements of operations. The Series B Preferred Stock was accounted for as Permanent Equity in accordance with ASC 480 - Distinguishing Liabilities from Equity. The fair value of the Series B Preferred Stock was allocated to par value of $Nil and additional paid-in capital of $47,553. On February 16, 2021, the Company extinguished all outstanding shares of its Series A Preferred Stock. In exchange, the former holders received one-year options to purchase up to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20210201__20210216__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CZJLicenseIncMember_zximo6FRBjJk">300,000 shares of the Company’s then wholly-owned subsidiary, CZJ License, Inc., at an exercise price of $10 per share. The fair value of the options issued was $21,465 and was included in additional paid-in capital. This transaction resulted in the derecognition of both the derivative liabilities and the Series A Preferred Stock. The difference between the combined carrying value of the derecognized derivative liabilities and Series A Preferred Stock and the $21,465 fair value of the options issued resulted in a gain on extinguishment of $194,685, which was recognized in the consolidated statements of operations for the year ended December 31, 2021. Separately, a loss of $20,657 resulting from the change in fair value of the derivative liabilities was recorded in the consolidated statements of operations for the year ended December 31, 2021. The options issued expired without exercise. The number of Series B Preferred Stock issued and outstanding as of March 31, 2026 and December 31, 2025 was <span id="xdx_906_ecustom--PreferredStockIssuedAndOutstanding_uUSD_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zU8SaeL3WPUh" title="Series B Preferred Stock issued and outstanding previous year"><span id="xdx_901_ecustom--PreferredStockIssuedAndOutstanding_uUSD_c20260101__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVdUDFjGoAEa" title="Series B Preferred Stock issued and outstanding current year">100. Series C Preferred Stock On February 11, 2021, the Company filed a certificate of designations of Series C Convertible Preferred Stock (the “Certificate of Designations”) with the Nevada Secretary of State designating <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20210211__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zPu0v5sBCkQ9" title="Preferred stock, shares authorized">10,000 shares of the Company’s shares of Preferred Stock as Series C Convertible Preferred Stock and setting forth the voting and other powers, preferences and relative, participating, optional or other rights of the Preferred Shares. Each share of Series C Preferred Stock has a par value of $0.001 per share and a stated value of $100 per share. Holders of the Series C Preferred Stock are entitled to vote on all matters submitted to the Company’s shareholders, with their voting power equivalent to the number of Common Stock shares they would hold if their preferred stock were converted. This voting right can be exercised through written consent or proxy. The Series C Preferred Stock does not have redemption rights. The Series C Preferred Stockholders are entitled to receive cumulative quarterly dividends, payable in additional Series A Preferred Stock, at an annual rate of 2% of the Stated Value, when declared by the Board. The Board did not declare dividend since issuance of the Series A Preferred Shares. The Company accounted for its Series C Preferred Stock as Mezzanine Equity in accordance with ASC 480, Distinguishing Liabilities from Equity. The embedded conversion feature of the preferred stock was evaluated under ASC 815, Derivatives and Hedging, and was concluded to qualify for derivatives. The Company did not issue Series C Preferred Stock. As at March 31, 2026 and December 31, 2025, no shares of Series C Preferred Stock are outstanding. Series D Preferred Stock On March 26, 2021, the Company filed a certificate of designations of Series D Convertible Preferred Stock (the “Certificate of Designations”) with the Nevada Secretary of State designating <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20210326__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zfmmYqget1C" title="Preferred stock, shares authorized">230,000 shares of the Company’s shares of Preferred Stock as Series D Convertible Preferred Stock and setting forth the voting and other powers, preferences and relative, participating, optional or other rights of the Preferred Shares. Each share of Series C Preferred Stock has a par value of $0.001 per share and a stated value of $3.32 per share. The Series D Preferred Stock has no voting rights. The Series D Preferred Stock does not have redemption rights. The Series D are ranked equally with the Series E Preferred Stock and the Series F Preferred Stock and as senior to all previously issued series of Preferred Stock and the Common Stock. The Series D Preferred Stockholders is entitled to receive dividends when declared by the Board. The Board did not declare a dividend since the issuance of the Series D Preferred Shares. Each share of Series D Preferred Stock may be converted into <span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_pid_uShares_c20210301__20210326__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zSjcervuLSag" title="Preferred stock, shares converted">1,000 common shares, subject to a 4.99% conversion limitation, which may be increased to a maximum of 9.99% by a holder by written notice to the Company. The Series D Preferred Stock was accounted for as Permanent Equity in accordance with ASC 480 - Distinguishing Liabilities from Equity. During the year ended December 31, 2021, the Company issued 230,000 shares of Series D Preferred Stock to settle several notes payable and accrued interest. The fair value of the Series D Preferred Stock issued was determined to be $1,006,035 by using debt-based valuation method, which was allocated to par value of $230 and additional paid-in capital of $1,005,805. During the year ended December 31, 2021, <span id="xdx_90E_eus-gaap--ConversionOfStockSharesConverted1_pid_uShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zP0u5PYGv3h9" title="Preferred stock, shares converted">75,000 shares of the Company’s Series D Preferred Stock were converted into <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zjKTDGofXdY5">75,000,000 shares of its Common Stock. As of March 31, 2026 and December 31, 2025, 155,000 shares of Series D Preferred Stock remain unconverted and outstanding. Series E Preferred Stock and Series E-1 Preferred Stock On March 26, 2021, the Company filed a certificate of designations of Series E Convertible Preferred Stock (the “Certificate of Designations”) with the Nevada Secretary of State designating <span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20210326__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zQRoQbrHoLB9" title="Preferred stock, shares authorized">1,000 shares of the Company’s shares of Preferred Stock as Series E Convertible Preferred Stock and setting forth the voting and other powers, preferences and relative, participating, optional or other rights of the Preferred Shares. Each share of Series E Preferred Stock has a par value of $<span id="xdx_906_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_uUSDPShares_c20210326__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zeQ7imdFhpH4" title="Par value, per share">0.001 per share and a stated value of $1,000 per share. The Series E are ranked equally with the Series D Preferred Stock and the Series F Preferred Stock and as senior to all previously issued series of Preferred Stock and the Common Stock. Each Holder of Series E Preferred Stock is entitled to vote on an as-converted basis, with the number of votes equal to the underlying Common Stock shares their Series E Preferred Stock would represent on the voting record date, and shall otherwise have the same voting rights as Common Stock. The Series E Preferred Stock does not have redemption rights. The Series E Preferred Stockholders is entitled to receive dividends when declared by the Board. The Board did not declare dividend since issuance of the Series E Preferred Shares. The Company accounted for its Series E Preferred Stock as permanent equity in accordance with ASC 480, Distinguishing Liabilities from Equity. The embedded conversion feature of the preferred stock was evaluated under ASC 815, Derivatives and Hedging, and was separated from the host instrument. The original embedded conversion feature was recognized as a derivative liability, with changes in its fair value recorded in the consolidated statements of operations at each reporting period end. Upon the issuance of the Series E Preferred Stock, the Company recognized derivative liabilities of $744. Subsequent to the issuance date, the Company evaluated an amendment to the conversion rate and determined that the amended conversion feature did not result in the recognition of a new derivative liability or a significant modification requiring remeasurement under ASC 815. On September 16, 2021, the Company filed a certificate of designations of Series E-1 Convertible Preferred Stock (the “Certificate of Designations”) with the Nevada Secretary of State designating <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20210916__us-gaap--StatementClassOfStockAxis__custom--SeriesEOnePreferredStockMember_zh3N0XIsXdY3" title="Preferred stock, shares authorized">1,152,500 shares of the Company’s shares of Preferred Stock as Series E-1 Convertible Preferred Stock and setting forth the voting and other powers, preferences and relative, participating, optional or other rights of the Preferred Shares. Each share of Series E Preferred Stock has a par value of $0.001per share and a stated value of $0.87 per share. The Series E-1 are ranked equally with the Series D Preferred Stock and the Series F Preferred Stock and as senior to all previously issued series of Preferred Stock and the Common Stock. Each Holder of Series E-1 Preferred Stock is entitled to vote on an as-converted basis, with the number of votes equal to the underlying Common Stock shares their Series E-1 Preferred Stock would represent on the voting record date and shall otherwise have the same voting rights as Common Stock. The Series E-1 Preferred Stock does not have redemption rights. The Series E-1 Preferred Stockholders is entitled to receive dividends when declared by the Board. The Board did not declare dividend since issuance of the Series E-1 Preferred Shares. The holder of the Series E-1 Preferred Stock may convert Series E-1 Preferred Shares into Common Stock at conversion rate of 1:1,000. The Series E-1 Preferred Stock was accounted for as Permanent Equity in accordance with ASC 480 - Distinguishing Liabilities from Equity. The fair value of the Series E-1 Preferred Stock was allocated to par value of $1 and additional paid-in capital of $386,220. On October 11, 2021, 1,000 shares of Series E Preferred Stock were exchanged for <span id="xdx_90F_eus-gaap--ConversionOfStockSharesIssued1_pid_uShares_c20211001__20211011__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesEOnePreferredStockMember_zZyc3pI87eZd">1,152,500 Series E-1 Preferred shares and <span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_pid_uShares_c20211001__20211011__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqYp03UKDdj">1,091,388,889 shares of Common Stock. We valued the exchange at the same $386,221 value as was assigned to the 1,000 shares of Series E Preferred Stock. Upon the exchange of the Series E Preferred Stock for Series E-1 Preferred Stock, the Company derecognized the related derivative liabilities during year ended December 31, 2021. As at March 31, 2026 and December 31, 2025, no shares of Series E Preferred Stock are outstanding. As of March 31, 2026 and December 31, 2025, <span id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_dxL_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesEOnePreferredStockMember_zVNpvZl0aVYk" title="Preferred stock, shares outstanding::XDX::1152500"><span id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_dxL_uShares_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesEOnePreferredStockMember_zKbwdI8zrmoj" title="Preferred stock, shares outstanding::XDX::1152500">1,152,000 shares of Series E-1 Preferred Stock are outstanding. Series F Preferred Stock During year ended December 31, 2021, the Company filed a certificate of designations of Series F Convertible Preferred Stock (the “Certificate of Designations”) with the Nevada Secretary of State designating <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_z56qu2wEdBrb" title="Preferred stock, shares authorized">1,000 shares of the Company’s shares of Preferred Stock as Series F Convertible Preferred Stock and setting forth the voting and other powers, preferences and relative, participating, optional or other rights of the Preferred Shares. Each share of Series E Preferred Stock has a par value of $<span id="xdx_90C_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_uUSDPShares_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zzpWMnQnffi3" title="Par value, per share">0.001 per share and a stated value of $1.00 per share. <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember__us-gaap--LongtermDebtTypeAxis__us-gaap--SeniorNotesMember_zdLFPjDWFoBb">1,000 shares of Series F Preferred Stock were issued along with the Senior Secured Notes (Note 8) The Series F Preferred Stock are ranked equally with the Series D Preferred Stock and the Series E Preferred Stock and as senior to all previously issued series of Preferred Stock and the Common Stock. Each Holder of Series F Preferred Stock is entitled to vote on an as-converted basis, with the number of votes equal to the underlying Common Stock shares their Series F Preferred Stock would represent on the voting record date and shall otherwise have the same voting rights as Common Stock. The Series F Preferred Stock does not have redemption rights. The Series F Preferred Stockholders is entitled to receive dividends when declared by the Board. The Board did not declare dividends since the issuance of the Series F Preferred Shares. The Company accounted for its Series F Preferred Stock as permanent equity in accordance with ASC 480, Distinguishing Liabilities from Equity. The fair value of the Series F Preferred Stock issued was determined to be $32,229 by using fully-diluted method, which was allocated to par value of $Nil and additional paid-in capital of $32,229. On October 11, 2021, the <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20211001__20211011__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zVXDor4qtW9e">1,000 shares of Series F Preferred Stock were converted into 192,073,017 shares of Common Stock. As of March 31, 2026 and December 31, 2025, <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_pid_dxL_uShares_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_z23sSA6P4D9k" title="Preferred Stock, Shares Issued::XDX::0"><span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dxL_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zYOG2BxCWQs7" title="Preferred Stock, Shares Outstanding::XDX::0">Nil shares of Series F Preferred Stock were issued and outstanding Series G Preferred Stock On March 26, 2021, the Company filed a certificate of designations of Series G Convertible Preferred Stock (the “Certificate of Designations”) with the Nevada Secretary of State designating <span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_uShares_c20210326__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zsoUnC8i6FP4" title="Preferred stock, shares authorized">3,000 shares of the Company’s shares of Preferred Stock as Series G Convertible Preferred Stock and setting forth the voting and other powers, preferences and relative, participating, optional or other rights of the Preferred Shares. Each share of Series E Preferred Stock has a par value of $<span id="xdx_908_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_uUSDPShares_c20210326__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_z0cflnetAVs9" title="Par value, per share">0.001 per share and a stated value of $1,000 per share. On August 18, 2021, the Company filed an amendment of certificate of designations and changed the designed number of Series G Convertible Preferred Stock from 3,000 to 4,600. The Series G are ranked equally with the Series D Preferred Stock and the Series E Preferred Stock and as senior to all previously issued series of Preferred Stock and the Common Stock. Each Holder of Series G Preferred Stock is entitled to vote on an as-converted basis, with the number of votes equal to the underlying Common Stock shares their Series E Preferred Stock would represent on the voting record date and shall otherwise have the same voting rights as Common Stock. The Series G Preferred Stock does not have redemption rights. The Series G Preferred Stockholders is entitled to receive dividends when declared by the Board. The Board did not declare dividend since issuance of the Series G Preferred Shares. During year ended December 31, 2021, the Company received $<span id="xdx_909_eus-gaap--PreferredStockSharesSubscribedButUnissuedValue_iI_uUSD_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zewu2QfwTDr1" title="Preferred stock, shares authorized">4,600,000 in subscriptions pursuant to the issuance of 4,600 of shares Series G Preferred Stock. The proceeds received was allocated into par value and additional paid-in capital of $5 and $4,599,995, respectively. On November 2, 2021, all the 4,600 shares of Series G Preferred Stock were converted into 255,555,556 shares of the Company’s Common Stock with a conversion price of $0.018 (Note 8). Upon conversion, the amount previously allocated into Series G par value of $5 was reclassified from Series G Preferred Stock to Common Stock’s par value with an additional increase of $255,551 in Common Stock’s par value and a decrease of 250,956 in additional paid-in capital. The Company accounted for its Series G Preferred Stock as permanent equity in accordance with ASC 480, Distinguishing Liabilities from Equity. The embedded conversion feature of the preferred stock was evaluated under ASC 815, Derivatives and Hedging, and was separated from the host instrument. The original embedded conversion feature was recognized as a derivative liability, with changes in its fair value recorded in the consolidated statements of operations at each reporting period end. Upon the issuance of the Series G Preferred Stock, the Company recognized derivative liabilities of $354,000. Subsequent to the issuance date, the Company evaluated an amendment to the conversion rate and determined that the amended conversion feature did not result in the recognition of a new derivative liability or a significant modification requiring remeasurement under ASC 815. Upon conversion to common stock, the abovementioned derivative liabilities were derecognized during the year ended December 31, 2021. Series H Preferred Stock On November 5, 2021, the Company filed a certificate of designations of Series H Convertible Preferred Stock (the “Certificate of Designations”) with the Nevada Secretary of State designating <span id="xdx_906_ecustom--TemporaryEquitySharesAuthorized1_iI_pid_uShares_c20211105__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z0NelIEgMP3" title="Temporary equity, shares authorized">39,895 shares of the Company’s shares of Preferred Stock as Series H Convertible Preferred Stock and setting forth the voting and other powers, preferences and relative, participating, optional or other rights of the Preferred Shares. Each share of Series H Preferred Stock has a par value of $<span id="xdx_909_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_uUSDPShares_c20211105__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zE2nx3gbWYLi" title="Temporary equity, stated value">0.001 per share and a stated value of $1.00 per share. Each Holder of Series H Preferred Stock is entitled to vote on an as-converted basis, with the number of votes equal to the underlying Common Stock shares their Series E Preferred Stock would represent on the voting record date and shall otherwise have the same voting rights as Common Stock. The Series H Preferred Stock does not have redemption rights. The Series H Preferred Stockholders are entitled to receive dividends when declared by the Board. The Board did not declare dividends since the issuance of the Series H Preferred Shares. The Series H Preferred Stock allowed holders to convert into common stock by a conversion ratio of 1:1,000. On November 11, 2021, pursuant to an exchange agreement that we entered into with the Investors, <span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_pid_uShares_c20211101__20211111__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zi9AspakuK">39,895,000 shares of Common Stock held by the Investors were exchanged for 39,895 shares of Series H Preferred Stock and the Company cancelled the <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_uShares_c20211101__20211111__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zvPUr144Mz2l">39,895,000 shares of common stock. The Company valued the 39,895,000 shares and 39,895 shares of Series H Preferred Stock at $<span id="xdx_90C_eus-gaap--ConversionOfStockAmountConverted1_c20211101__20211111__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zkoLYuNbmg4d">3,989,500. Upon exchange, $40 was reclassified from the amount previously allocated into Common Stock par value into Series H Preferred Stock’s par value with the remaining $39,855 reclassified into in additional paid-in capital. At March 31, 2026 and December 31, 2025, 39,895 shares of Series H Preferred Stock remain outstanding. Common Stock No issuances of Common Stock occurred in the three months ended March 31, 2026. On December 30, 2025, the Company issued 75,000,000 shares of Common Stock for repayment of $56,250 owed to the lender. No other issuances of Common Stock occurred in the years ended December 31, 2025. On January 31, 2026, the Company adopted the 2026 Omnibus Equity Incentive Plan (the “Plan”) and reserved 168,000,000 shares of Common Stock for Plan use. On August 14, 2021, our shareholders approved an increase in the authorized number of shares of Common Stock to 6,000,000,000, from 500,000,000, which became effective the same day. As of March 31, 2026 and December 31, 2025, there were 1,678,095,243 shares outstanding, respectively. Warrants We issued warrants issued as loan incentives and valued the warrants on their respective grant dates using the Black-Scholes option pricing model. Warrant values per share ranged from $0.023 to $0.002. For the three months ended March 31, 2026, a summary of our warrant activity is as follows: Schedule of warrant activity <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">Number of Warrants</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">Weighted- Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">Weighted- Average Remaining Contractual Term (Years)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">Weighted- Average Grant- Date Fair Value</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Outstanding and exercisable at January 1, 2026</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjy2xpeMtubj" style="width: 12%; text-align: right" title="Number of warrants, balance, beginning of year">243,323,017</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNDaT0wBlqe8" style="width: 12%; text-align: right" title="Weighted average exercise price, beginning of year">0.021</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingExcerisableContractualTerm2_dtY_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxEqIm1zO8v1" style="width: 12%; text-align: right" title="Weighted average life exercised (in years)">1.30</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedGrantDateFairValue_iS_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFAVl4KQAJ0b" style="width: 12%; text-align: right" title="Weighted average grant date fair value, beginning of period">1,963,079</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zoqXaAoaa9Xb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, expired">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Outstanding and exercisable at March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zj6EFv4n2Qu" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, balance, end of period">243,323,017</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEqCI8npMOsi" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending of year">0.021</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingExcerisableContractualEndTerm2_dtY_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zweIefIuQlsd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average life exercised (in years)">0.80</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedGrantDateFairValue_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zP7Vriosz2ub" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date fair value, end of period">1,963,079</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> In determining the fair value of these equity-classified features, the Company considered the fact that its common stock is quoted on the OTC Expert Market, where trading volume is minimal and pricing is not reliably observable. Due to the absence of active market inputs, the Company determined that a quoted market price could not be used to value the conversion features. Instead, the Company referred to the most recent observable transaction price from a private placement conducted in 2021, in which it issued <span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5XwVOpV5Gn8">4,600 shares of Series G Preferred Stock for total proceeds of $<span id="xdx_905_eus-gaap--PreferredStockValue_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zilB5WjmQDH2">4,600,000. On November 2, 2021, these preferred shares were converted into <span id="xdx_905_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_uShares_c20211102__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zsvlYtrqG26d">255,555,556 shares of common stock, implying an effective per-share price of $<span id="xdx_90D_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_uUSDPShares_c20211102__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zlZZHvMJfVFe">0.018. The Company used this price as the best available input to support the fair value assessment.

50000000

48460905 48460905

100000

0.001

100

Holders of the Series A Preferred Stock are entitled to vote on all matters submitted to the Company’s shareholders, with their voting power equivalent to the number of Common Stock shares they would hold if their preferred stock were converted. This voting right can be exercised through written consent or proxy.

3420

360000000 360000000

100

0.001

The shares of Series B Super Voting Preferred Stock will carry a number of votes equal to 51% (representing majority voting power) of all voting shares of every class, including 51% of all of the issued and outstanding shares of common stock on the date of any shareholder vote, such that the holders of Super Voting Preferred Stock shall always possess the majority of voting rights, and shall always out vote all holders of Common Stock.

100

92999

100

216150

47553

58545

20657

47553

300000

10 194685

20657

100 100

10000

0.001

100

Holders of the Series C Preferred Stock are entitled to vote on all matters submitted to the Company’s shareholders, with their voting power equivalent to the number of Common Stock shares they would hold if their preferred stock were converted. This voting right can be exercised through written consent or proxy.

230000

0.001

3.32

The Series D Preferred Stock has no voting rights.

1000

0.0499

230000

1006035

230

1005805

75000

75000000

155000

1000

0.001

1000

Each Holder of Series E Preferred Stock is entitled to vote on an as-converted basis, with the number of votes equal to the underlying Common Stock shares their Series E Preferred Stock would represent on the voting record date, and shall otherwise have the same voting rights as Common Stock.

1152500

0.001

0.87

Each Holder of Series E-1 Preferred Stock is entitled to vote on an as-converted basis, with the number of votes equal to the underlying Common Stock shares their Series E-1 Preferred Stock would represent on the voting record date and shall otherwise have the same voting rights as Common Stock.

386220

1152500

1091388889

386221

1000

0.001

1.00

1000

Each Holder of Series F Preferred Stock is entitled to vote on an as-converted basis, with the number of votes equal to the underlying Common Stock shares their Series F Preferred Stock would represent on the voting record date and shall otherwise have the same voting rights as Common Stock.

32229

1000

192073017

3000

0.001

1000

3000 4600

Each Holder of Series G Preferred Stock is entitled to vote on an as-converted basis, with the number of votes equal to the underlying Common Stock shares their Series E Preferred Stock would represent on the voting record date and shall otherwise have the same voting rights as Common Stock.

4600000

4599995

On November 2, 2021, all the 4,600 shares of Series G Preferred Stock were converted into 255,555,556 shares of the Company’s Common Stock with a conversion price of $0.018 (Note 8). Upon conversion, the amount previously allocated into Series G par value of $5 was reclassified from Series G Preferred Stock to Common Stock’s par value with an additional increase of $255,551 in Common Stock’s par value and a decrease of 250,956 in additional paid-in capital. 39895

0.001

1.00

Each Holder of Series H Preferred Stock is entitled to vote on an as-converted basis, with the number of votes equal to the underlying Common Stock shares their Series E Preferred Stock would represent on the voting record date and shall otherwise have the same voting rights as Common Stock.

39895000

3989500

39855

39895

75000000

56250

500000000

1678095243

Schedule of warrant activity <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">Number of Warrants</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">Weighted- Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">Weighted- Average Remaining Contractual Term (Years)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">Weighted- Average Grant- Date Fair Value</td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Outstanding and exercisable at January 1, 2026</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjy2xpeMtubj" style="width: 12%; text-align: right" title="Number of warrants, balance, beginning of year">243,323,017</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNDaT0wBlqe8" style="width: 12%; text-align: right" title="Weighted average exercise price, beginning of year">0.021</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingExcerisableContractualTerm2_dtY_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxEqIm1zO8v1" style="width: 12%; text-align: right" title="Weighted average life exercised (in years)">1.30</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedGrantDateFairValue_iS_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFAVl4KQAJ0b" style="width: 12%; text-align: right" title="Weighted average grant date fair value, beginning of period">1,963,079</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zoqXaAoaa9Xb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, expired">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Outstanding and exercisable at March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zj6EFv4n2Qu" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, balance, end of period">243,323,017</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEqCI8npMOsi" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending of year">0.021</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingExcerisableContractualEndTerm2_dtY_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zweIefIuQlsd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average life exercised (in years)">0.80</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedGrantDateFairValue_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zP7Vriosz2ub" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date fair value, end of period">1,963,079</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

243323017

0.021 P1Y3M18D 1963079

243323017

0.021 P0Y9M18D 1963079

4600

4600000

255555556

0.018

Note 10 Contingency and Commitments On February 17, 2024, Agile Capital Funding LLC (“Agile”) filed a Confession of Judgment executed by Philip Falcone with the Supreme Court of the State of New York, County of New York. The filing stated that Sovryn Holdings Inc. (“Sovryn”) and Madison Technologies Inc. (“Madison”) owe Agile an amount of approximately $190,444 as of February 17, 2024, representing funds received on January 30, 2023, net of repayments, together with accrued interest and collection fees. Management has reviewed this matter and concluded that Madison has no obligation arising from this Confession of Judgment. The funds in question were received by Sovryn, which was a subsidiary of Madison at the time and was sold to Arena Group Holdings Inc. in February 2023, including all of Sovryn’s assets and liabilities. Accordingly, management believes that the Confession of Judgment relates to obligations of Sovryn prior to its sale. Madison has not received any demand or claim for payment in connection with this matter. Based on the information available, management believes it is unlikely that this matter will result in any obligation for Madison. No amount has been recognized in the financial statements, as any potential liability, if any, cannot be reasonably determined at this time. Our principal executive office, at which minimal operations are conducted and which we do not own or lease, is located at 2500 Westchester Avenue, Suite 401, Purchase, New York. We do not have an employment agreement with our Chief Executive Officer.

190444

Note 11 Subsequent Events The Company has evaluated subsequent events through May 15, 2026, the date the financial statements were available to be issued. On May 5, 2026, the Company issued 83,333,333 shares of unregistered Common Stock in satisfaction of a conversion notice submitted by a lender for partial repayment of our debt. Subsequent to March 31, 2025, the Company received $258,918 in additional funding from its principal shareholder, Arena. These funds were provided to support the Company’s ongoing operations and working capital requirements. Management believes that this continued financial support from Arena demonstrates the shareholder’s commitment and provides the Company with sufficient liquidity to continue operations for the foreseeable future. Other than the above, management has determined that there are no other subsequent events.

83333333

258918

false false false false